Carmine Zoccali

Q: What Schools Are Affiliated With Carmine Zoccali

Carmine Zoccali is affiliated with the following schools: University of Catania, University of Parma, University of Bari, University of Palermo, Aristotle University of Thessaloniki

Carmine Zoccali's AcademicInfluence.com Rankings

Carmine Zoccali

Philosophy

#3487

World Rank

#5627

Historical Rank

Logic

#1188

World Rank

#1872

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Carmine Zoccali's Degrees

Doctorate Medicine University of Bari
PhD Nephrology University of Bari

Why Is Carmine Zoccali Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Carmine Zoccali is an Italian nephrologist and a clinical investigator. He has contributed to research in several fields, most notably hypertension and cardiovascular complications in chronic kidney disease , CKD progression and clinical epidemiology of kidney diseases at large. He is known for his studies on cardiovascular risk in CKD and dialysis patients. He was among the earliest investigators that focused on the relevance of endothelial dysfunction and inflammation for the high risk of cardiovascular disease in these populations. In this research area, he was the first to link endogenous inhibitors of the nitric oxide system with death and cardiovascular disease. and the first to document a relationship between sympathetic over-activity and these outcomes Dr Zoccali is a practicing specialist in Nephrology, with a national qualification for the full professorship in Nephrology. He is also a specialist in hypertension, certified by the European Society of Hypertension .

(See a Problem?)

Carmine Zoccali's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study (2001) (1078)
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria (1999) (862)
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. (2002) (807)
Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. (2003) (748)
Kidney disease: Improving global outcomes (KDIGO) blood pressure work group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease (2012) (637)
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial (2005) (585)
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. (2012) (558)
Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease (2002) (501)
When do we need competing risks methods for survival analysis in nephrology? (2013) (497)
Vitamin D levels and patient outcome in chronic kidney disease. (2009) (421)
Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules. (2002) (416)
Subjective global assessment of nutrition in dialysis patients. (1993) (400)
CKD Prevalence Varies across the European General Population. (2016) (390)
Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. (2005) (385)
Sample size calculations: basic principles and common pitfalls. (2010) (355)
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe (2020) (331)
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure (2014) (328)
Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. (2002) (328)
Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. (2004) (327)
Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. (2001) (324)
Confounding: what it is and how to deal with it. (2008) (313)
Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. (2001) (299)
Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. (2002) (296)
The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. (2006) (296)
Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease. (2009) (291)
Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. (2005) (281)
Obesity and kidney disease: hidden consequences of the epidemic (2017) (272)
Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. (2005) (264)
Cohort Studies: Prospective versus Retrospective (2009) (260)
Chronic Fluid Overload and Mortality in ESRD. (2017) (258)
Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. (2010) (247)
Detection of pulmonary congestion by chest ultrasound in dialysis patients. (2010) (237)
Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. (2006) (233)
Exercise in Patients on Dialysis: A Multicenter, Randomized Clinical Trial. (2017) (233)
Inflammation is associated with carotid atherosclerosis in dialysis patients (2000) (231)
Survival analysis: time-dependent effects and time-varying risk factors. (2008) (229)
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients. (2002) (225)
Pulmonary congestion predicts cardiac events and mortality in ESRD. (2013) (225)
The systemic nature of CKD (2017) (218)
Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? (2002) (216)
Insulin resistance in chronic kidney disease: a systematic review. (2016) (214)
Traditional and emerging cardiovascular risk factors in end-stage renal disease. (2003) (211)
Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. (2001) (211)
A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. (2019) (210)
Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. (2004) (205)
Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. (2006) (205)
Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. (2011) (205)
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice (2016) (204)
Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. (2001) (203)
Selection Bias and Information Bias in Clinical Research (2010) (197)
Sample Size Calculations (2011) (194)
Uric acid and endothelial dysfunction in essential hypertension. (2006) (194)
Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. (2001) (193)
Diagnostic methods I: sensitivity, specificity, and other measures of accuracy. (2009) (190)
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action (2017) (186)
The aging kidney revisited: A systematic review (2014) (180)
Low triiodothyronine and survival in end-stage renal disease. (2006) (180)
In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia. (1999) (178)
Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. (2010) (178)
The analysis of survival data: the Kaplan-Meier method. (2008) (175)
Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? (2005) (175)
Effects of weight loss on renal function in obese CKD patients: a systematic review. (2013) (173)
Diagnostic potential of cardiac natriuretic peptides in dialysis patients. (2001) (171)
Novel cardiovascular risk factors in end-stage renal disease. (2004) (170)
Obesity in CKD--what should nephrologists know? (2013) (168)
Nocturnal hypoxemia predicts incident cardiovascular complications in dialysis patients. (2002) (165)
Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients. (2006) (165)
FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. (2010) (164)
The effect of joint exposures: examining the presence of interaction. (2009) (164)
Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. (2002) (162)
Low triiodothyronine: a new facet of inflammation in end-stage renal disease. (2005) (162)
Cardiovascular risk in uraemic patients-is it fully explained by classical risk factors? (2000) (161)
An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. (2009) (160)
External validation of prognostic models: what, why, how, when and where? (2020) (154)
When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study. (2011) (153)
Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. (2001) (149)
Monocyte subpopulations and cardiovascular risk in chronic kidney disease (2012) (149)
Adiponectin in essential hypertension. (2002) (143)
Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial. (2012) (141)
Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. (2005) (136)
Use of phosphate-binding agents is associated with a lower risk of mortality. (2013) (135)
The double challenge of resistant hypertension and chronic kidney disease (2015) (134)
Norepinephrine and Concentric Hypertrophy in Patients With End-Stage Renal Disease (2002) (134)
Graphical presentation of confounding in directed acyclic graphs. (2015) (132)
Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. (2003) (131)
Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis. (2006) (131)
Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients (2010) (128)
Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. (2006) (128)
Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients. (1998) (128)
ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease. (2003) (126)
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (2019) (125)
Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease. (2012) (122)
Lipid management in patients with chronic kidney disease (2018) (119)
ACE inhibition is renoprotective among obese patients with proteinuria. (2011) (119)
Screening for chronic kidney disease: where does Europe go? (2008) (119)
A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. (2019) (118)
Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). (2012) (118)
Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients. (2005) (117)
Mechanisms of cognitive dysfunction in CKD (2020) (117)
Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term (2018) (114)
The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study. (2016) (114)
Blood temperature and vascular stability during hemodialysis and hemofiltration. (1982) (113)
Paricalcitol and Endothelial Function in Chronic Kidney Disease Trial (2014) (113)
Pulmonary hypertension in CKD. (2013) (113)
Obesity and kidney disease: hidden consequences of the epidemic (2017) (110)
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. (2010) (108)
Dissecting inflammation in ESRD: do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients? (2006) (108)
Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen) (2000) (108)
Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology (2014) (106)
Endothelial Dysfunction and Mild Renal Insufficiency in Essential Hypertension (2004) (106)
Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review (2018) (106)
Inflammation and asymmetric dimethylarginine for predicting death and cardiovascular events in ESRD patients. (2011) (105)
ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease. (2006) (104)
Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients: CREED investigators. (1999) (102)
Effect of extracorporeal blood cooling on dialytic arterial hypotension. (1981) (102)
Multiple imputation: dealing with missing data. (2013) (100)
Chronic kidney disease prevalence in the general population: heterogeneity and concerns. (2016) (99)
The use of hook plate in type III and V acromio-clavicular Rockwood dislocations: clinical and radiological midterm results and MRI evaluation in 42 patients. (2012) (99)
Prognosis of CKD patients receiving outpatient nephrology care in Italy. (2011) (97)
Left atrial volume in end-stage renal disease: a prospective cohort study (2006) (96)
Inflammation and Atherosclerosis in End-Stage Renal Disease (2003) (94)
Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease. (2004) (92)
Bias in clinical research. (2008) (91)
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1. (2000) (90)
Sleep apnea in renal patients. (2001) (89)
Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update (2020) (89)
Survival Analysis I: The Kaplan-Meier Method (2011) (89)
Linear and logistic regression analysis. (2008) (89)
Predictors of cardiovascular death in ESRD. (2005) (88)
Agreement between methods. (2008) (88)
Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections. (2007) (88)
Adipose tissue as a source of inflammatory cytokines in health and disease: focus on end-stage renal disease. (2003) (88)
Chronic kidney disease and end-stage renal disease—a review produced to contribute to the report ‘the status of health in the European union: towards a healthier Europe’ (2009) (85)
Endothelial Dysfunction and C-Reactive Protein Are Risk Factors for Diabetes in Essential Hypertension (2008) (84)
Fibrinogen, mortality and incident cardiovascular complications in end‐stage renal failure (2003) (84)
Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry. (2014) (84)
Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients (2017) (84)
The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care. (2012) (81)
Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients. (2002) (78)
The endothelium as a target in renal diseases. (2007) (78)
The valuable contribution of observational studies to nephrology. (2007) (78)
Autonomic neuropathy is linked to nocturnal hypoxaemia and to concentric hypertrophy and remodelling in dialysis patients. (2001) (77)
Achievement of target blood pressure levels in chronic kidney disease: a salty question? (2004) (77)
Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients. (1986) (76)
Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease. (2004) (76)
Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study. (2007) (76)
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey. (2015) (76)
Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease (2006) (75)
Measures of Disease Frequency: Prevalence and Incidence (2010) (73)
Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients. (1999) (73)
Out-of-office blood pressure monitoring in chronic kidney disease (2009) (73)
Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients. (2013) (72)
Chest ultrasound and hidden lung congestion in peritoneal dialysis patients. (2012) (72)
The analysis of survival data in nephrology: basic concepts and methods of Cox regression. (2008) (72)
Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles (2016) (71)
Statistical methods for the assessment of prognostic biomarkers (Part I): discrimination. (2010) (71)
Genetic Mapping in the Xp11.2 Region of a New Form of X-Linked Hypophosphatemic Rickets (1993) (70)
European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP). (2008) (70)
The importance of diabetic nephropathy in current nephrological practice. (2003) (69)
Physical Performance and Clinical Outcomes in Dialysis Patients: A Secondary Analysis of the Excite Trial (2014) (69)
Obesity and Kidney Disease (2017) (69)
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. (2013) (68)
Clinical management of the uraemic syndrome in chronic kidney disease. (2016) (67)
Radiofrequency ablation versus magnetic resonance guided focused ultrasound surgery for minimally invasive treatment of osteoid osteoma: a propensity score matching study (2016) (67)
Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta‐Analysis (2018) (67)
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. (2008) (67)
Salivary and lacrimal secretion is reduced in patients with ESRD. (2003) (67)
Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move. (2006) (66)
Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man. (1984) (66)
Study Designs in Clinical Research (2009) (66)
Assessment of obesity in chronic kidney disease: what is the best measure? (2012) (66)
Prediction versus aetiology: common pitfalls and how to avoid them: Clinical Epidemiology in Nephrology (2017) (66)
Risk prediction models. (2013) (66)
Mazabraud’s syndrome: a new case and review of the literature (2009) (65)
Diagnostic methods 2: receiver operating characteristic (ROC) curves. (2009) (65)
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses (2018) (65)
Epidemiology of CKD in Europe: an uncertain scenario. (2010) (64)
Genetic polymorphism of the renin–angiotensin–aldosterone system and arterial hypertension in the Italian population: the GENIPER Project (2003) (64)
Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease. (2010) (64)
Methylarginines and mortality in patients with end stage renal disease: a prospective cohort study. (2009) (63)
Matching, an Appealing Method to Avoid Confounding? (2011) (63)
Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease (2008) (62)
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD. (2015) (62)
Low Triiodothyronine Alters Flow-Mediated Vasodilatation in Advanced Nondiabetic Kidney Disease (2010) (62)
Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension. (2006) (61)
Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review (2015) (61)
Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study (2017) (61)
Mendelian randomization: use of genetics to enable causal inference in observational studies. (2010) (61)
Intention to treat and per protocol analysis in clinical trials (2020) (61)
Left ventricular systolic function monitoring in asymptomatic dialysis patients: a prospective cohort study. (2006) (60)
Greater fluid overload and lower interdialytic weight gain are independently associated with mortality in a large international hemodialysis population (2018) (60)
Left ventricular hypertrophy and nocturnal hypoxemia in hemodialysis patients (2001) (59)
Testing for causality and prognosis: etiological and prognostic models. (2008) (59)
The role of minimally invasive lateral lumbar interbody fusion in sagittal balance correction and spinal deformity (2014) (59)
Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients. (2005) (58)
Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario? (2014) (57)
Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end‐stage renal disease (ESRD) patients (2010) (57)
The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial. (2019) (57)
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity. (2014) (57)
Defective reflex control of heart rate in dialysis patients: evidence for an afferent autonomic lesion. (1982) (57)
Klotho Variants and Chronic Hemodialysis Mortality (2009) (56)
The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda (2011) (56)
The role of FDG-PET in distinguishing between septic and aseptic loosening in hip prosthesis: a review of literature (2009) (56)
Endogenous ouabain and cardiomyopathy in dialysis patients (2008) (56)
Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients. (2004) (55)
Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all‐cause and cardiovascular mortality in haemodialysis patients (2011) (55)
An introduction to inverse probability of treatment weighting in observational research (2021) (55)
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients. (2013) (55)
Biomarkers of Left Atrial Volume: A Longitudinal Study in Patients With End Stage Renal Disease (2009) (55)
Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR) (2018) (55)
Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring Methods, Thresholds, and Patterns (2016) (55)
Measures of effect: relative risks, odds ratios, risk difference, and 'number needed to treat'. (2007) (54)
Association of a polymorphism in a gene encoding a urate transporter with CKD progression. (2014) (54)
Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. (2000) (53)
Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease. (2015) (53)
Asymptomatic pulmonary congestion and physical functioning in hemodialysis patients. (2013) (53)
Rate of atherosclerotic plaque formation predicts cardiovascular events in ESRD. (2008) (52)
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? (2018) (52)
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement. (2008) (51)
Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention. (2002) (51)
Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-project. (2016) (51)
The 2006 ERA-EDTA Registry annual report: a précis. (2009) (50)
Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: a secondary analysis of the EXCITE trial (2018) (50)
Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow—implications for CKD and cardiovascular disease (2011) (50)
The Tokuhashi score: effectiveness and pitfalls (2016) (50)
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update. (2018) (49)
Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease. (2011) (49)
Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease. (2003) (49)
Uric Acid, Hypertension, and Cardiovascular and Renal Complications (2013) (48)
Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients. (2005) (48)
Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease? (2006) (48)
Plasma adrenomedullin during acute changes in intravascular volume in hemodialysis patients. (1998) (47)
Survival Analysis II: Cox Regression (2011) (47)
Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link? (2011) (47)
The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. (2007) (46)
Intradialysis Hypertension in End-Stage Renal Disease Patients: Clinical Epidemiology, Pathogenesis, and Treatment (2015) (46)
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis (2012) (46)
10.16 Inflammation as a Mediator of the Link Between Mild to Moderate Renal Insufficiency and Endothelial Dysfunction in Essential Hypertension (2006) (45)
Mild cognitive impairment and kidney disease: clinical aspects. (2019) (44)
AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications. (2000) (44)
Mendelian randomization: a new approach to studying epidemiology in ESRD. (2006) (44)
Observational Studies Are Complementary to Randomized Controlled Trials (2009) (44)
Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system. (2005) (43)
Cultural adaptation and validation of the “Kidney Disease and Quality of Life - Short Form (KDQOL-SF™) version 1.3” questionnaire in Egypt (2012) (43)
Obesity and kidney disease: hidden consequences of the epidemic (2017) (43)
Effect of renal artery stenting on left ventricular mass: a randomized clinical trial. (2012) (43)
Longitudinal Analysis of Vascular Function and Biomarkers of Metabolic Bone Disorders before and after Renal Transplantation (2013) (42)
Stratification for Confounding – Part 1: The Mantel-Haenszel Formula (2010) (42)
Does high salt intake cause hyperfiltration in patients with essential hypertension? (1996) (42)
Reproducibility of the response to short-term low salt intake in essential hypertension (1996) (42)
Inflammation, Endothelial Dysfunction and Increased Left Ventricular Mass in Chronic Kidney Disease (CKD) Patients: A Longitudinal Study (2015) (42)
Organ donation and transplantation: a multi-stakeholder call to action (2021) (42)
Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial (2012) (42)
Postprandial alterations in arterial pressure control during hemodialysis in uremic patients. (1989) (41)
The obesity epidemics in ESRD: from wasting to waist? (2008) (41)
Estimated Glomerular Filtration Rate, All-Cause Mortality and Cardiovascular Diseases Incidence in a Low Risk Population: The MATISS Study (2013) (40)
Obesity and nephrology: results of a knowledge and practice pattern survey. (2013) (40)
Statistical methods for the assessment of prognostic biomarkers(part II): calibration and re-classification. (2010) (40)
The randomized clinical trial: an unbeatable standard in clinical research? (2007) (40)
Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients. (2011) (39)
Measuring Agreement, More Complicated Than It Seems (2012) (39)
Vitamin D Receptor Activation and Left Ventricular Hypertrophy in Advanced Kidney Disease (2011) (39)
Vasopressin beyond water: implications for renal diseases (2010) (39)
Urinary and plasma endothelin 1 in essential hypertension and in hypertension secondary to renoparenchymal disease. (1995) (39)
Pentosidine, carotid atherosclerosis and alterations in left ventricular geometry in hemodialysis patients. (2001) (38)
Obesity and kidney disease: Hidden consequences of the epidemic (2017) (38)
Sleep Disordered Breathing in Renal Transplant Patients (2009) (38)
Lung Ultrasound-Guided Dry Weight Assessment and Echocardiographic Measures in Hypertensive Hemodialysis Patients: A Randomized Controlled Study. (2019) (38)
The 2007 ERA-EDTA Registry Annual Report—a Précis (2009) (38)
Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function. (2007) (38)
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study (2014) (38)
Stratification for Confounding – Part 2: Direct and Indirect Standardization (2010) (37)
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure (2003) (37)
Merits and caveats of propensity scores to adjust for confounding. (2018) (37)
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine. (2019) (36)
High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease. (2015) (36)
Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients. (2013) (36)
Convection versus diffusion in dialysis: an Italian prospective multicentre study. (2003) (36)
Body mass index trend in haemodialysis patients: the shift of nutritional disorders in two Italian regions. (2016) (36)
Measuring disease occurrence. (2007) (36)
Magnetic-resonance-guided focused ultrasound treatment of non-spinal osteoid osteoma in children: multicentre experience (2019) (36)
Prognostic value of the New York Heart Association classification in end-stage renal disease. (2007) (36)
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics. (2018) (35)
Arterial pressure components and cardiovascular risk in end-stage renal disease. (2003) (35)
The enzymatic machinery for ADMA synthesis and degradation is fully expressed in human adipocytes. (2007) (35)
Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe. (2018) (35)
The relationship between hemoglobin levels and endothelial functions in diabetes mellitus. (2009) (35)
Blood pressure control: hydrogen sulfide, a new gasotransmitter, takes stage. (2009) (35)
Residual neurological function after sacral root resection during en-bloc sacrectomy: a systematic review (2016) (34)
Lung Congestion as a Risk Factor in End-Stage Renal Disease (2013) (34)
Adiponectin and leptin in chronic kidney disease: causal factors or mere risk markers? (2011) (34)
The Role of Deconditioning in the End-Stage Renal Disease Myopathy: Physical Exercise Improves Altered Resting Muscle Oxygen Consumption (2015) (34)
Double-blind randomized, crossover trial of calcium supplementation in essential hypertension. (1988) (34)
Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients (2013) (34)
Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease. (2009) (34)
Systematic reviews and meta-analyses: when they are useful and when to be careful. (2009) (34)
Gender-dependent differences in plasma leptin in essential hypertension. (2000) (34)
Obesity and kidney disease: hidden consequences of the epidemic. (2017) (34)
Lung Ultrasound in the Management of Fluid Volume in Dialysis Patients: Potential Usefulness (2017) (34)
Interventions for preventing the progression of autosomal dominant polycystic kidney disease. (2015) (33)
Asymmetric dimethylarginine predicts survival in the elderly (2013) (33)
International differences in chronic kidney disease prevalence: a key public health and epidemiologic research issue: Clinical Epidemiology in Nephrology (2017) (33)
Cardiac consequences of hypertension in hemodialysis patients. (2004) (33)
Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease. (2006) (33)
A new technique for biopsy of soft tissue neoplasms: a preliminary experience using MRI to evaluate bleeding. (2015) (32)
Prevalence and Prognosis of Mild Anemia in Non-Dialysis Chronic Kidney Disease: A Prospective Cohort Study in Outpatient Renal Clinics (2010) (32)
Ultrafiltration intensification in hemodialysis patients improves hypertension but increases AV fistula complications and cardiovascular events. (2011) (31)
Risk, Predictors, and Outcomes of Acute Kidney Injury in Patients Admitted to Intensive Care Units in Egypt (2017) (31)
Renal safety of catheter‐based renal denervation: systematic review and meta‐analysis (2017) (31)
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. (2012) (31)
Stenting of renal artery stenosis in coronary artery disease (RAS-CAD) study: a prospective, randomized trial. (2009) (31)
HYPERTENSION IN HEMODIALYSIS PATIENTS: Cardiac Consequences of Hypertension in Hemodialysis Patients (2004) (31)
Overweight, obesity and metabolic alterations in chronic kidney disease. (2009) (31)
Evolution of the imaging features of osteoid osteoma treated with RFA or MRgFUS during a long-term follow-up: a pictorial review with clinical correlations (2020) (31)
Effects of potassium on sodium balance, renin, noradrenaline and arterial pressure. (1985) (31)
Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials. (2019) (30)
Effect of simvastatin on plasma asymmetric dimethylarginine concentration in patients with chronic kidney disease. (2008) (30)
Endothelial Damage, Asymmetric Dimethylarginine and Cardiovascular Risk in End-Stage Renal Disease (2002) (30)
Microalbuminuria, endothelial dysfunction and inflammation in primary hypertension. (2007) (30)
Pulmonary Congestion and Physical Functioning in Peritoneal Dialysis Patients (2012) (30)
Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease. (2008) (30)
Apabetalone Mediated Epigenetic Modulation is Associated with Favorable Kidney Function and Alkaline Phosphatase Profile in Patients with Chronic Kidney Disease (2018) (30)
Clinical Epidemiology of Major Nontraditional Risk Factors in Peritoneal Dialysis Patients (2005) (30)
The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD. (2018) (30)
Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management (2020) (30)
Serum Alkaline Phosphatase Negatively Affects Endothelium-Dependent Vasodilation in Naïve Hypertensive Patients (2015) (30)
QUality European STudies (QUEST)--a step forward in the quality of RRT care. (2005) (29)
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD). (2012) (29)
Development and testing of an artificial intelligence tool for predicting end stage kidney disease in patients with immunoglobulin A nephropathy. (2020) (29)
An overview on standard statistical methods for assessing exposure-outcome link in survival analysis (Part II): the Kaplan-Meier analysis and the Cox regression method (2012) (29)
The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease (2005) (29)
A genetic marker of uric acid level, carotid atherosclerosis, and arterial stiffness: a family-based study. (2015) (29)
Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS). (2008) (29)
Where to look for the most frequent biases? (2020) (28)
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease (2003) (28)
Thyroid function and clinical outcomes in kidney failure. (2012) (28)
Parathyroidectomy and blood pressure in hemodialysis patients. (1993) (28)
A randomized multicenter trial on a lung ultrasound guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk. (2021) (28)
Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension. (2008) (28)
Management of hypertension in chronic kidney disease: the Italian multicentric study. (2005) (27)
The quality of reporting in clinical research: the CONSORT and STROBE initiatives (2013) (27)
Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD. (2015) (27)
The ENPP1 Q121 Variant Predicts Major Cardiovascular Events in High-Risk Individuals (2011) (27)
The issue of studying the effect of interventions in renal replacement therapy -- to what extent may we be deceived by selection and competing risk? (2010) (27)
Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients (2008) (27)
The databases: renal replacement therapy since 1989--the European Renal Association and European Dialysis and Transplant Association (ERA-EDTA). (2009) (27)
Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides. (2005) (27)
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis. (2019) (27)
Gammaglutamyltransferase in ESRD as a predictor of all-cause and cardiovascular mortality: another facet of oxidative stress burden. (2008) (27)
Cardiovascular and renal medicine, an expanding territory (2011) (27)
Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension. Salt Sensitivity Group of Italian Society of Hypertension. (2001) (27)
Hepatocyte Growth Factor and Left Ventricular Geometry in End-Stage Renal Disease (2003) (27)
Non‐proteinuric rather than proteinuric renal diseases are the leading cause of end‐stage kidney disease: Clinical Epidemiology in Nephrology (2017) (26)
The burden of physical inactivity in chronic kidney disease: is there an exit strategy? (2012) (26)
Influence of blood temperature on vascular stability during hemodialysis and isolated ultrafiltration. (1985) (26)
Epidemiology of CKD Regression in Patients under Nephrology Care (2015) (26)
Leptin and biochemical markers of bone turnover in dialysis patients. (2004) (26)
The heart rate response pattern to dialysis hypotension in haemodialysis patients. (1997) (25)
The deletion polymorphism of the angiotensin-converting enzyme is associated with nephroangiosclerosis. (2000) (25)
Patient‐reported outcome measures ( PROMs): making sense of individual PROM scores and changes in PROM scores over time (2020) (25)
Obesity and kidney disease: Hidden consequences of the epidemic. (2017) (25)
Nocturnal Hypertension and Altered Night–Day BP Profile and Atherosclerosis in Renal Transplant Patients (2016) (25)
Data from the ERA-EDTA Registry was examined for trends in excess mortality in European adults on kidney replacement therapy. (2020) (24)
Urotensin II and biomarkers of endothelial activation and atherosclerosis in end-stage renal disease. (2006) (24)
Conducting correlation analysis: important limitations and pitfalls (2021) (24)
Low parathyroid hormone and pentosidine in hemodialysis patients. (2002) (24)
Hypertension as a cardiovascular risk factor in end-stage renal failure (2002) (24)
Screening: why, when, and how. (2009) (24)
The surgical neurovascular anatomy relating to partial and complete sacral and sacroiliac resections: a cadaveric, anatomic study (2015) (24)
Subclinical pulmonary congestion is prevalent in nephrotic syndrome. (2016) (24)
Circulating E‐selectin as a risk marker in patients with end‐stage renal disease (2007) (24)
FGF23: A Mature Renal and Cardiovascular Risk Factor? (2013) (24)
Nebivolol Improves Renal Function in Patients Who Underwent Angioplasty due to Renal Artery Stenosis: A Pilot Study (2009) (24)
Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in Chronic Kidney Disease Patients. (2019) (24)
Nocturnal Hypoxemia: A Neglected Cardiovascular Risk Factor in End-Stage Renal Disease? (2002) (24)
How to increase kidney transplant activity throughout Europe-an advocacy review by the European Kidney Health Alliance. (2019) (24)
Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD). (2003) (24)
Comparison of Wells and Revised Geneva Rule to Assess Pretest Probability of Pulmonary Embolism in High‐Risk Hospitalized Elderly Adults (2015) (24)
Parasympathetic function in haemodialysis patients. (1986) (24)
How important is echocardiography for risk stratification in follow-up of patients with chronic kidney disease? (2007) (23)
Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension. (1984) (23)
Procalcitonin and the inflammatory response to salt in essential hypertension: a randomized cross-over clinical trial (2013) (23)
Influence of cardiovascular damage and residual renal function on plasma endothelin in chronic renal failure. (1993) (23)
Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA. (2018) (23)
Endothelial dysfunction in CKD: a new player in town? (2007) (23)
Moderator's view: Ambulatory blood pressure monitoring and home blood pressure for the prognosis, diagnosis and treatment of hypertension in dialysis patients. (2015) (23)
Left ventricular systolic dysfunction: a sudden killer in end-stage renal disease patients. (2010) (23)
Adiponectin and renal disease progression: another epidemiologic conundrum? (2007) (23)
A long term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies (1991) (23)
Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis. (2019) (23)
Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease. (2019) (23)
HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance (2018) (23)
Plasma met-enkephalin and leu-enkephalin in chronic renal failure. (1987) (23)
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease (2018) (23)
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance. (2013) (22)
Giant cell tumor of bone in a patient with diagnosis of primary hyperparathyroidism: a challenge in differential diagnosis with brown tumor (2014) (22)
Pitfalls of linear regression for estimating slopes over time and how to avoid them by using linear mixed-effects models. (2019) (22)
Effect of ultrafiltration on plasma concentrations of atrial natriuretic peptide in haemodialysis patients. (1986) (22)
ERA-EDTA invests in transformation to greener health care. (2018) (22)
Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients (2018) (22)
How to Deal with Continuous and Dichotomic Outcomes in Epidemiological Research: Linear and Logistic Regression Analyses (2011) (22)
Reporting of Interaction (2011) (22)
Validity of Vascular Calcification as a Screening Tool and as a Surrogate End Point in Clinical Research. (2015) (22)
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy. (2015) (21)
Intact FGF23 and α‐klotho during acute inflammation/sepsis in CKD patients (2016) (21)
Obesity and Kidney Disease: Hidden Consequences of the Epidemic. (2017) (21)
Sleep apnoea and nocturnal hypoxaemia in dialysis patients: mere risk-indicators or causal factors for cardiovascular disease? (2000) (21)
Ramipril Lowers Plasma FGF-23 in Patients with Diabetic Nephropathy (2014) (21)
Biomarkers in chronic kidney disease: utility and issues towards better understanding (2005) (21)
Pulse Wave Velocity and Prognosis in End-Stage Kidney Disease (2018) (21)
Obesity and kidney disease: hidden consequences of the epidemic (2017) (21)
Antiproteinuric effect of Losartan in patients with chronic renal diseases. (1997) (21)
The complexity of the cardio–renal link: taxonomy, syndromes, and diseases (2011) (21)
Case-Control Studies – An Efficient Observational Study Design (2009) (21)
The sacral chordoma margin. (2020) (21)
The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease (2011) (21)
Urotensin II and Cardiomyopathy in End-Stage Renal Disease (2008) (21)
Multimodal treatment of calcific uraemic arteriolopathy (calciphylaxis): a case series (2015) (21)
Prediction and consistency of blood pressure salt-sensitivity as assessed by a rapid volume expansion and contraction protocol. Salt-Sensitivity Study Group of the Italian Society of Hypertension. (2000) (21)
Data Sharing Under the General Data Protection Regulation (2021) (21)
Confounding (2010) (21)
A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation. (2015) (21)
The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease. (2006) (20)
Measuring asymmetric dimethylarginine (ADMA) in CKD: a comparison between enzyme-linked immunosorbent assay and liquid chromatography-electrospray tandem mass spectrometry. (2012) (20)
Glitazones in chronic kidney disease: potential and concerns. (2012) (20)
Intralesional vs. extralesional procedures for low-grade central chondrosarcoma: a systematic review of the literature (2018) (20)
The Randomized Controlled Trial (2009) (20)
Blood temperature and cardiovascular stability in hemofiltration. (1983) (20)
The MAURO study: baseline characteristics and compliance with guidelines targets. (2012) (20)
Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study (2012) (20)
A genetic marker of hyperuricemia predicts cardiovascular events in a meta-analysis of three cohort studies in high risk patients. (2015) (19)
An unusual localization of chondroblastoma: The triradiate cartilage; from a case report a reconstructive technique proposal with imaging evolution. (2017) (19)
The Innate Immune System And Cardiovascular Disease In Eskd: Monocytes And Natural Killer Cells. (2020) (19)
Intact FGF23 and α‐klotho during acute inflammation/sepsis in CKD patients (2017) (19)
Epithelioid hemangioendothelioma of the spine: results at seven years of average follow-up in a series of 10 cases surgically treated and a review of literature (2015) (19)
eNOS and caveolin-1 gene polymorphisms interaction and intima media thickness: a proof of concept study in ESRD patients. (2012) (19)
The salt epidemic: old and new concerns. (2000) (18)
Obesity and kidney disease: Hidden consequences of the epidemic (2017) (18)
Neuropeptide Y and chronic kidney disease progression: a cohort study. (2018) (18)
Obesity, diabetes, adiponectin and the kidney: a podocyte affair. (2008) (18)
Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study. (2019) (18)
The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal man. (1983) (18)
Obesity and kidney disease: hidden consequences of the epidemic (2017) (18)
Survival of patients treated with extended-hours haemodialysis in Europe: an analysis of the ERA-EDTA Registry (2019) (18)
Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA. (2018) (18)
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. (2021) (18)
Respiratory muscle impairment in dialysis patients: can minimal dose of exercise limit the damage? A Preliminary study in a sample of patients enrolled in the EXCITE trial (2016) (18)
Salvage Revision Surgery After Inappropriate Approach for Primary Spine Tumors: Long Term Follow-Up in 56 Cases. (2017) (17)
Thyroid Function Test Derangements and Mortality in Dialysis Patients: A Systematic Review and Meta-analysis. (2016) (17)
Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. (2016) (17)
Design and methodology of the screening for CKD among older patients across Europe (SCOPE) study: a multicenter cohort observational study (2018) (17)
Interaction on an Additive Scale (2011) (17)
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis (2020) (17)
Bracing After Surgical Stabilization of Thoracolumbar Fractures: A Systematic Review of Evidence, Indications, and Practices. (2016) (17)
Clinical policies on the management of chronic kidney disease patients in Italy. (2007) (16)
Obesity and Kidney Disease: Hidden Consequences of the Epidemic (2017) (16)
Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: Managing Volume Overload. (2018) (16)
Renal endothelin-1 is linked to changes in urinary salt and volume in essential hypertension. Salt Sensitivity Group of the Italian Society of Hypertension. (2000) (16)
Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: post hoc analysis of a multicentre, randomized and controlled trial. (2014) (16)
CT radiomics-based machine learning classification of atypical cartilaginous tumours and appendicular chondrosarcomas (2021) (16)
A look at the upper heart chamber: the left atrium in chronic kidney disease. (2014) (16)
Surgical anatomy of the minimally invasive lateral lumbar approach (2015) (16)
Biofabricating murine and human myo‐substitutes for rapid volumetric muscle loss restoration (2021) (16)
Spontaneous compartment syndrome in a patient with diabetes and statin administration: a case report (2008) (16)
Uric acid in chronic kidney disease: the quest for causality continues. (2018) (16)
Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end-stage renal disease. (2005) (16)
Nonproteinuric progressive diabetic kidney disease (2019) (16)
A Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal Study (2016) (16)
Comorbidity data collection by renal registries--a remaining challenge. (2009) (15)
Left Ventricular Mass Index as an Outcome Measure in Clinical Trials in Dialysis Patients: A Word of Caution (2011) (15)
Instrumental variable analysis. (2013) (15)
Neuropeptide Y as a far-reaching neuromediator: from energy balance and cardiovascular regulation to central integration of weight and bone mass control mechanisms. Implications for human diseases (2005) (15)
Can the assessment of ultrasound lung water in haemodialysis patients be simplified? (2020) (15)
Oxidative Stress as Estimated by Gamma-Glutamyl Transferase Levels Amplifies the Alkaline Phosphatase-Dependent Risk for Mortality in ESKD Patients on Dialysis (2016) (15)
Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them (2020) (15)
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: a time-integrated analysis (2017) (15)
The future of European Nephrology ‘Guidelines’—a declaration of intent by European Renal Best Practice (ERBP) (2009) (15)
Asymmetric dimethylarginine in end-stage renal disease patients: a biomarker modifiable by calcium blockade and angiotensin II antagonism? (2006) (15)
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study (2019) (15)
Obesity and the epidemiology and prevention of kidney disease: waist circumference versus body mass index. (2011) (15)
The surgical vascular anatomy of the minimally invasive lateral lumbar interbody approach: a cadaveric and radiographic analysis (2015) (14)
A paradigm for the evaluation and management of spinal coccidioidomycosis (2015) (14)
The use of echocardiography in observational clinical trials: the EURECA-m registry. (2013) (14)
The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity. (2012) (14)
Lung Ultrasound-Guided Dry-Weight Reduction in Hemodialysis Patients Does Not Affect Short-Term Blood Pressure Variability. (2019) (14)
Another ‘Epidemic’ of Spontaneous Rupture of Peritoneal Catheters (1998) (14)
An introduction to joint models—applications in nephrology (2020) (14)
Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial. (2019) (14)
Snoring Amplifies the Risk of Heart Failure and Mortality in Dialysis Patients (2014) (14)
The Carbofix™ "Piccolo Proximal femur nail": A new perspective for treating proximal femur lesion. A technique report. (2016) (14)
Long-term blood pressure monitoring by office and 24-h ambulatory blood pressure in renal transplant patients: a longitudinal study. (2018) (14)
Traditional and nontraditional risk factors as predictors of cerebrovascular events in patients with end stage renal disease (2010) (14)
The influence of salt intake on plasma calcitonin gene‐related peptide in subjects with mild essential hypertension (1994) (13)
Moderator's view: Vitamin D deficiency treatment in advanced chronic kidney disease: a close look at the emperor's clothes. (2016) (13)
Fitness for Entering a Simple Exercise Program and Mortality: A Study Corollary to the Exercise Introduction to Enhance Performance in Dialysis (Excite) Trial (2014) (13)
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage. (2021) (13)
Obesity and Kidney Disease: Hidden Consequences of the Epidemic (2017) (13)
18F-FDG PET/CT in the evaluation of cartilaginous bone neoplasms: the added value of tumor grading (2019) (13)
Evidence‐based medicine—When observational studies are better than randomized controlled trials (2020) (13)
The \ ( ENPP 1 \ ) Q 121 Variant Predicts Major Cardiovascular Events in High-Risk Individuals (2011) (13)
An additive effect of endothelial nitric oxide synthase gene polymorphisms contributes to the severity of atherosclerosis in patients on dialysis. (2007) (13)
Biopsy can determinate tumoral track contamination: A case report of chondrosarcoma (2009) (13)
FGF-23 in dialysis patients: ready for prime time? (2008) (12)
Homocysteine and risk in end-stage renal disease: a matter of context. (2006) (12)
Diagnostic and Clinical Impact of 18F-FDG PET/CT in Staging and Restaging Soft-Tissue Sarcomas of the Extremities and Trunk: Mono-Institutional Retrospective Study of a Sarcoma Referral Center (2020) (12)
Pruritus and quality of life in renal transplant patients (2017) (12)
Obesity and kidney disease: Hidden consequences of the epidemic. (2017) (12)
Magnetic resonance-guided focused ultrasound surgery treatment of non-spinal intra-articular osteoblastoma: feasibility, safety, and outcomes in a single-center retrospective analysis (2019) (12)
Fibrinogen and calcium x phosphate product are predictors of cardiovascular events in the CAPD population. (2005) (12)
Arteriovenous fistula as a nephroprotective intervention in advanced CKD: scientific discovery and explanation, and the evaluation of interventions. (2015) (12)
A green light for troponin T in the cardiovascular risk stratification of continuous ambulatory peritoneal dialysis patients? (2006) (12)
Providing guidance in the dark: rare renal diseases and the challenge to improve the quality of evidence. (2014) (12)
Major pathways of the reno–cardiovascular link: the sympathetic and renin–angiotensin systems (2011) (11)
Adma: a critical cardio‐renal link in heart failure? (2003) (11)
Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients. (2016) (11)
Health economics and European Renal Best Practice--is it time to bring health economics into evidence-based guideline production in Europe? (2014) (11)
Spleen IL-10, a key player in obesity-driven renal risk. (2013) (11)
Optimizing hypertension management in renal transplantation: a call to action. (2017) (11)
Hypertension in kidney transplantation: a consensus statement of the ‘hypertension and the kidney’ working group of the European Society of Hypertension (2021) (11)
ACE and α‐adducin genotypes and renal disease progression (2000) (11)
Ultrafiltration for the treatment of congestion: a window into the lung for a better caress to the heart. (2014) (11)
Assessment of the salt-arterial pressure relationship in mild hypertensive subjects by 24-hour ambulatory monitoring. (1994) (11)
Obesity and Kidney Disease: Hidden Consequences of the Epidemic. (2017) (11)
The dual mobility cup in muscular skeletal oncology: rationale and indications (2017) (11)
Effect of naloxone on the defective autonomic control of heart rate in uraemic patients. (1985) (11)
Atherosclerosis in dialysis patients: does Chlamydia pneumoniae infection contribute to cardiovascular damage? (2002) (11)
Obesity and kidney disease: Hidden consequences of the epidemic (2017) (11)
Estimation of glomerular filtration rate in patients with normal serum creatinine undergoing primary PCI : is it really normal ? (2006) (11)
Engineering Human-Scale Artificial Bone Grafts for Treating Critical-Size Bone Defects. (2019) (11)
Longitudinal association of body mass index and waist circumference with left ventricular mass in hypertensive predialysis chronic kidney disease patients (2013) (11)
The influence of autonomic failure on plasma ANF concentration in uremic patients on chronic hemodialysis. (1992) (11)
Lung congestion as a hidden threat in end-stage kidney disease: a call to action. (2013) (11)
A polymorphism in a major antioxidant gene (Kelch-like ECH-associated protein 1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study (2016) (11)
The Surgical Anatomy of the Lumbosacroiliac Triangle: A Cadaveric Study. (2016) (11)
Faculty Opinions recommendation of Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. (2018) (10)
Pulmonary hypertension in dialysis patients: a prevalent, risky but still uncharacterized disorder. (2012) (10)
Appraising prediction research: risk of bias and applicability assessment of prognostic models using the PROBAST. (2021) (10)
Osteoid osteoma treated with radiofrequency ablation in non-operating room anesthesia. A different way of approaching ablative therapy on osteoid osteoma. (2018) (10)
Pleiotropic effects of angiotensin II blockers in hemodialysis patients: myth or reality? (2014) (10)
[Clinical trials (Part I)]. (2010) (10)
Reappraisal in two European cohorts of the prognostic power of left ventricular mass index in chronic kidney failure. (2017) (10)
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression. (2015) (10)
Quality of care in end-stage renal disease: the importance of comparing 'apples with apples'. (2007) (10)
Adding Up the Evidence: Systematic Reviews and Meta-Analyses (2011) (10)
Asymmetric dimethylarginine (ADMA) as a cardiovascular risk factor in end-stage renal disease (ESRD) (2006) (10)
Asymmetric and Symmetric Dimethylarginine and Sympathetic Nerve Traffic after Renal Denervation in Patients with Resistant Hypertension. (2015) (10)
The 'breakpoint' test, a new statistical method for studying progression of chronic renal failure. (1989) (10)
Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels. (2017) (10)
Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients (2010) (10)
Moderator's view: Pretransplant weight loss in dialysis patients: cum grano salis. (2015) (10)
Optimizing hypertension management in renal transplantation: a call to action. (2017) (10)
Should patients with CKD stage 5 D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy ? An ERA-EDTA position statement (2015) (9)
Serum phosphorus levels are associated with endothelial dysfunction in hypertensive patients. (2016) (9)
Biological markers of inflammation and carpal tunnel syndrome in dialysis patients. (1990) (9)
Moderator's view: Low-protein diet in chronic kidney disease: effectiveness, efficacy and precision nutritional treatments in nephrology. (2018) (9)
Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in CKD Patients (2019) (9)
Nomenclature in nephrology: preserving ‘renal’ and ‘nephro' in the glossary of kidney health and disease (2021) (9)
The continuous challenge of cardiovascular and bone and bone disease in uremic patients: clinical consequences of hyperphosphatemia and advanced therapeutic approaches. (2006) (9)
Clinical and radiological midterm results from using the Fixion expandable intramedullary nail in transverse and short oblique fractures of femur and tibia (2008) (9)
The reflex control of vasopressin in haemodialysis patients. (1991) (9)
Neuropeptide Y and markers of osteoblast activity in dialysis patients: a cross-sectional study. (2007) (9)
CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: It Is Important to Lower Homocysteine in Dialysis Patients (2007) (9)
Bibliometric analysis of the scientific productivity of the Italian Society of Nephrology for a period of five consecutive years (1990-1994). (1996) (9)
Catheter-based renal denervation as a novel treatment for loin pain haematuria syndrome. (2013) (9)
The fate of triaged and rejected manuscripts. (2015) (9)
Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease (2018) (9)
Appraising prediction research: a guide and meta‐review on bias and applicability assessment using the Prediction model Risk Of Bias ASsessment Tool (PROBAST) (2021) (9)
Clinical implications of elevated asymmetric dimethylarginine in chronic kidney disease and end-stage renal disease. (2009) (9)
Randomly allocated crossover study of various levels of sodium intake in patients with mild hypertension (1993) (9)
Does adipose tissue have a key role in inflammation in CKD? (2011) (9)
Chronic Kidney Disease (CKD) as a Systemic Disease: Whole Body Autoregulation and Inter-Organ Cross-Talk (2014) (9)
Kidney Diseases in the Developing World and Ethnic Minorities (2006) (9)
Long-Term Progression of Coronary Artery Calcification Is Independent of Classical Risk Factors, C-Reactive Protein, and Parathyroid Hormone in Renal Transplant Patients (2017) (9)
The burden of cardiovascular disease in patients with chronic kidney disease and in end-stage renal disease. (2008) (9)
Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: a post hoc analysis of a double-blind, randomized clinical trial (2018) (9)
Neuropeptide Y predicts cardiovascular events in chronic kidney disease patients: a cohort study. (2019) (8)
Light-chain nephropathy in patient with renal carcinoma. (1981) (8)
The QUEST initiative anemia study in ESRD: rationale and study protocol. (2007) (8)
Prognostic values of left ventricular mass index in chronic kidney disease patients. (2019) (8)
Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe (2019) (8)
Assessing physical activity and function in patients with chronic kidney disease: a narrative review (2020) (8)
Pelvic sacral and hemi lumbar spine resection of low grade pelvic chondrosarcoma: a multistage procedure involving vascular bypass, spine fixation and vascular exclusion. (2013) (8)
Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients (2018) (8)
Aging and Left Ventricular Mass and Function in People with End‐Stage Renal Disease (2011) (8)
Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment (2021) (8)
ACE and alpha-adducin genotypes and renal disease progression. (2000) (8)
FGF23 and the PTH response to paricalcitol in chronic kidney disease (2019) (8)
Joint effect of insulin signaling genes on all-cause mortality. (2014) (8)
Obesity and kidney disease: Hidden consequences of the epidemic (2017) (8)
Reorganization Tips from a Sarcoma Unit at Time of the COVID-19 Pandemic in Italy: Early Experience from a Regional Referral Oncologic Center (2020) (8)
Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling. (2012) (8)
Electronic publishing: now and tomorrow. (1998) (8)
Moderator's view: Phosphate binders in chronic kidney disease patients: a clear 'No' at the moment, but stay tuned. (2015) (8)
Heart rate, age and the risk of progression to kidney failure in patients with CKD. (2012) (8)
Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient. (1996) (8)
Ectopic primary type A thymoma located in two thoracic vertebras: a case report (2010) (8)
Clinical Databases and the QUEST Initiative (2007) (8)
20-Hydroxyeicosatetraenoic acid, a far-reaching autacoid in chronic kidney disease: hypertension and beyond. (2015) (8)
Antibacterial hydrogel coating in joint mega-prosthesis: results of a comparative series (2021) (8)
Excess volume removal following lung ultrasound evaluation decreases central blood pressure and pulse wave velocity in hemodialysis patients: a LUST sub-study (2020) (7)
Hyperchloraemia: a non-specific finding in chronic renal failure. (1985) (7)
Linee guida. Identificazione, prevenzione e gestione della malattia renale cronica nell'adulto (2012) (7)
Lactic acidosis induced by phenformin is still a public health problem in Italy (1997) (7)
Preoperative radiofrequency ablation in painful osteolytic long bone metastases. (2012) (7)
The QUEST initiative anemia study in transplant patients: rationale and study protocol. (2007) (7)
A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community (2020) (7)
[18F]FDG PET/CT quantitative parameters for the prediction of histological response to induction chemotherapy and clinical outcome in patients with localised bone and soft-tissue Ewing sarcoma (2021) (7)
Biofabricating murine and human myo-substitutes for rapid volumetric muscle loss restoration (2020) (7)
The MAURO study: multiple intervention and audit in renal diseases to optimize care. (2008) (7)
Obesity and Kidney Disease: Hidden Consequences of the Epidemic (2017) (7)
Relation of Blood Pressure and Body Sodium Content During Sodium Depletion in Normal and Hypertensive Subjects (1984) (7)
Arthroscopic guided biopsy and radiofrequency thermoablation of a benign neoplasm of the tibial spines area: a treatment option (2012) (7)
En bloc spondylectomy in patients older than 60 years: indications, results and complications in a series of 37 patients (2019) (7)
3D-Printed Titanium Custom-Made Prostheses in Reconstruction after Pelvic Tumor Resection: Indications and Results in a Series of 14 Patients at 42 Months of Average Follow-Up (2021) (7)
Surgical Site Infections in Treatment of Musculoskeletal Tumors: Experiencefrom a Single Oncologic Orthopedic Institution (2016) (7)
Urine chloride self-measurement to monitor sodium chloride intake in patients with chronic kidney disease (2019) (7)
Is the Posterior-Only Approach Sufficient for Treating Cervical Spine Metastases? The Evidence from a Case Series. (2019) (7)
Measures of Effect in Epidemiological Research (2010) (7)
Effects of Ketanserin, a New Selective Serotonin Antagonist, on Blood Pressure and the Renin-Aldosterone System in Sodium-Depleted Normal Subjects (1982) (7)
Clinical databases in nephrology: research and clinical practice goals and challenges. (2006) (6)
The lingering dilemma of arterial pressure in CKD: what do we know, where do we go? (2011) (6)
Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial. (2018) (6)
Diabetes, sarcopenia and chronic kidney disease; the Screening for CKD among Older People across Europe (SCOPE) study (2022) (6)
Lag-censoring analysis: lights and shades. (2015) (6)
Serum gamma-glutamyltransferase, oxidized LDL and mortality in the elderly (2019) (6)
Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients. (2016) (6)
The advantages of carbon fiber-based orthopedic devices in patients who have to undergo radiotherapy: an experimental evidence (2020) (6)
Obesity and Kidney Disease: Hidden Consequences of the Epidemic (2017) (6)
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area (2018) (6)
An overview of standard statistical methods for assessing exposure-outcome link in survival analysis (Part I): basic concepts (2012) (6)
Sleep Apnea as a Cardiorenal Risk Factor in CKD and Renal Transplant Patients (2021) (6)
Chronic kidney disease certification process manual by the Italian Society of Nephrology (SIN): Part I: clinical care delivery and performance measurements and improvement. (2009) (6)
[Hyperhomocysteinemia and progression of renal disease]. (2005) (6)
Left ventricular hypertrophy in chronic kidney disease (2018) (6)
Causal mechanism and component causes in Mesoamerican-Sri Lankan nephropathy: the moderator's view. (2017) (6)
Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology (2020) (6)
Should We Continue Assessing Glomerular Filtration Rate with the Cockroft–Gault Formula in NOAC-Treated Patients? The Magnitude of the Problem (2020) (6)
The overdriven glomerulus as a cardiovascular risk factor. (2018) (6)
Novel markers of graft outcome in a cohort of kidney transplanted patients: a cohort observational study (2019) (6)
The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council. (2018) (6)
Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients (2017) (5)
Anterior robotic approach in en-bloc sacrectomy: a preliminary experience (2019) (5)
Risk factors: Hyperhomocysteinemia: a renal and cardiovascular risk factor? (2010) (5)
En bloc resection in patients younger than 16 years affected by primary spine tumors: indications, results and complications in a series of 22 patients (2020) (5)
Pulmonary embolism in chronic kidney disease: a lethal, overlooked and research orphan disease (2012) (5)
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis (2021) (5)
A comparative study of the risk profile of hemodialysis patients in a for profit network and in two regional registries of the Italian Society of Nephrology (2018) (5)
Long-term propranolol treatment of resistant arterial hypertension in haemodialysed patients. (1975) (5)
Coronary heart disease extension as a predictor of atherosclerotic renal artery stenosis. (2008) (5)
Phosphate Binders and Clinical Outcomes in Patients with Stage 5D Chronic Kidney Disease (2015) (5)
[Diagnostic tests and ROC curves analysis]. (2011) (5)
The Role Of Financial Indicators In The Life Of Italian Football Clubs (2011) (5)
The influence of volume depletion and central hypovolemia on the plasma concentration of parathyroid hormone in dialysis patients. (1997) (5)
Prevalence and treatment of carpal tunnel syndrome in renal haemodialysis. (2005) (5)
Lancet Countdown paper: what does it mean for nephrology? (2018) (5)
Obesity and kidney disease: hidden consequences of the epidemic (2017) (5)
Obesity and kidney disease: hidden consequences of the epidemic. (2017) (5)
Cardiovascular protection by β-blockade in hypertensive haemodialysis patients: the Hypertension in Haemodialysis Patients Treated With Atenolol or Lisinopril (HDPAL) trial. (2014) (5)
Soluble E-Selectin Is an Inverse and Independent Predictor of Left Ventricular Wall Thickness in End-Stage Renal Disease Patients (2009) (5)
Faculty Opinions recommendation of Renin-Angiotensin-Aldosterone System Blockers and the Risk of COVID-19. (2020) (5)
The dominant prognostic value of physical functioning among quality of life domains in end-stage kidney disease. (2018) (5)
Aldosterone, mortality, cardiovascular events and reverse epidemiology in end stage renal disease (2015) (5)
Prediction of hypertension in hemodialysis patients. (2002) (5)
Vitamin D and methylarginines in chronic kidney disease (CKD) (2017) (5)
Genetic Association Studies: Discovery of the Genetic Basis of Renal Disease (2011) (5)
Sleep‐Disordered Breathing and 24‐Hour Ambulatory Blood Pressure Monitoring in Renal Transplant Patients: Longitudinal Study (2020) (5)
Endothelial Dysfunction and CRP Are Risk Factors for Diabetes in Essential Hypertension (2007) (5)
Faculty of 1000 evaluation for Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial. (2018) (5)
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease (2019) (5)
The sirtuin1 gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study (2018) (5)
Is the KDIGO Systolic Blood Pressure Target <120 mm Hg for Chronic Kidney Disease Appropriate in Routine Clinical Practice? (2021) (5)
Severe hypothyroidism induced by amiodarone in a dialysis patient. (1987) (5)
Causality at the dawn of the 'omics' era in medicine and in nephrology. (2016) (4)
Obesity and kidney disease: hidden consequences of the epidemic (2016) (4)
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure. (2012) (4)
Erratum to: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA. (2019) (4)
Evidence-based medicine: the clinician's perspective. (1999) (4)
Mechanism of hypercalciuria in essential hypertension and in primary nephrolithiasis. (1991) (4)
Faculty Opinions recommendation of Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. (2020) (4)
The effectiveness of a standard drill connected to a core biopsy needle: How to obtain specimens in very strong bone tumors. (2018) (4)
The role of endogenous opioids in the baroreflex dysfunction of dialysis patients. (1985) (4)
Funnel plots of patient‐reported outcomes to evaluate health‐care quality: Basic principles, pitfalls and considerations (2020) (4)
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial. (2020) (4)
[Guidelines for ambulatory monitoring of kidney transplant patients. Adaptation of the Guidelines of the American Society of Transplantation (J Am Soc Nephrol 2000; 11 (S1): 86)]. (2004) (4)
Norepinephrine, left ventricular disorders and volume excess in ESRD (2015) (4)
Nephrology: achieving sustainability. (2020) (4)
Intermediate grade vertebral osteosarcoma in a patient affected by a sacral chondrosarcoma and hereditary multiple exostosis. (2015) (4)
A new perspective for the treatment of renal diseases? (2007) (4)
Prognostic models in the clinical arena (2012) (4)
Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study. (2020) (4)
Funding kidney research as a public health priority: challenges and opportunities. (2020) (4)
Hyperfiltration and calcium metabolism in essential hypertension. (1991) (4)
Lung ultrasound to detect and monitor pulmonary congestion in patients with acute kidney injury in nephrology wards: a pilot study (2019) (4)
Salt sensitivity phenotype: a death bell toll or a quest for better ways of testing the risk associated with 'sodium genes'? (2003) (4)
An unusual case of lumbar paravertebral miositis ossificans mimicking muscular skeletal tumor (2013) (4)
Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients. (2018) (4)
A cyanoacrylate and silastic patch to reduce the risk of opening of the tumor: technical note. (2013) (4)
Moderator's view: Salt, cardiovascular risk, observational research and recommendations for clinical practice. (2016) (4)
Kidney disease 1 Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure (2014) (4)
Type-2 diabetes and endothelial dysfunction: exploring the road to disease in the reverse direction. (2008) (4)
Chronic kidney disease epidemics--a gap in effectiveness: the distance between potential and actual treatment benefits. (2006) (4)
Interventional Radiology in the Management of Metastases and Bone Tumors (2022) (4)
Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges (2021) (4)
CKD-MBD Biomarkers and CKD Progression: an Analysis by the Joint Model. (2022) (4)
Management of Osteoblastoma and Giant Osteoid Osteoma with Percutaneous Thermoablation Techniques (2021) (4)
Needleless Ablation of Osteoid Osteoma and Osteoblastoma: The Emergent Role of MRgFUS (2021) (3)
Ranolazine can markedly increase tacrolimus blood levels (2010) (3)
Detecting and Treating Lung Congestion with Kidney Failure. (2022) (3)
Medical Knowledge, Quality of Life and Accreditation of Quality in Health Care the Perspective of the Clinical Nephrologist (1998) (3)
Engineering of human bone with Plexur M™ in acetabular roof reconstruction after curettage of a giant aggressive aneurismal bone cyst of the left emypelvis. (2015) (3)
Sarcoma patients' quality of life from diagnosis to yearly follow-up: experience from an Italian tertiary care center. (2019) (3)
The nephrology crystal ball: the medium-term future. (2019) (3)
ADPKD - CLINICAL OUTCOME STUDIES (2014) (3)
Dialysis: The sweetness of glitazones: randomized trials needed (2009) (3)
Be careful with ecological associations (2021) (3)
Moderator's view: Meta-analysis: the best knowledge but not always shining gold. (2016) (3)
Endothelial Dysfunction, Nitric Oxide Bioavailability, and Asymmetric Dimethyl Arginine (2010) (3)
Ensuring optimal care for people with kidney disease during the COVID-19 pandemic (2020) (3)
The IlluminOss® photodynamic bone stabilization system for pathological osteolyses and fractures of the humerus: indications, advantages and limits in a series of 12 patients at 24 months of minimum follow‐up (2021) (3)
What makes plaques vulnerable in CKD?: a fresh look at metalloproteinases. (2010) (3)
The importance of large, high quality clinical databases in nephrology. (2001) (3)
General and clinical epidemiology at square two: a new educational series for the renal physician. (2007) (3)
Arthroscopic patterns of the poster-medial aspect of the knee joint: classification of the gastrocnemius-semimembranosus gateway and its relationship with Baker's cyst. (2016) (3)
Influence of ANF on the cardiovascular response to volume expansion in haemodialysis patients. (1994) (3)
Renal impairment: a risk factor for ischemic heart disease. (2006) (3)
[Confounding in epidemiology]. (2010) (3)
Moderator's view: Predictive models: a prelude to precision nephrology. (2017) (3)
Sympathoinhibitory effects of statins in chronic kidney disease: are they clinically relevant? (2011) (3)
10. Hypertension. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism. (1983) (3)
Report from the editorial offices. (2012) (3)
Long-Term Changes in Sleep Disordered Breathing in Renal Transplant Patients: Relevance of the BMI (2020) (3)
Gdansk bio-statistic and epidemiology course. (2001) (3)
A multiplanar complex resection of a low-grade chondrosarcoma of the distal femur guided by K-wires previously inserted under CT-guide: a case report (2014) (3)
Promoting scientific collaboration and education in cardiovascular–renal medicine (2009) (3)
The cost of knowledge in nephrology and the importance of clinical databases. (2000) (3)
Can there be science without philosophy? (2016) (3)
Cardiovascular risk in patients with chronic kidney disease: Not high enough to enter the major league? (2008) (3)
Propranolol treatment of resistant arterial hypertension in patients on chronic dialysis. (1975) (3)
Ambulatory blood pressure changes with lung ultrasound-guided dry-weight reduction in hypertensive hemodialysis patients: 12-month results of a randomized controlled trial (2021) (2)
FC 114LUNG ULTRASOUND-GUIDED ULTRAFILTRATION IN HAEMODIALYSIS PATIENTS REDUCES THE RISK OF DIALYSIS HYPOTENSION (2021) (2)
The challenge of Mendelian randomization approach (2017) (2)
[OP.7D.04] NOCTURNAL HYPERTENSION AND PROGRESSIVE RENAL FUNCTION LOSS IN RENAL TRANSPLANT PATIENTS (2017) (2)
Automatic identification of variables in epidemiological datasets using logic regression (2017) (2)
Corrigendum to “Glitazones in chronic kidney disease: Potential and concerns” [Nutr Metab Cardiovasc Dis 22 (2012) 167–175] (2013) (2)
The European Certificate in Nephrology: towards harmonization and excellence in training (2018) (2)
Nocturnal Hypoxemia: A Cardiovascular Risk Factor in Dialysis Patients (1998) (2)
Chemotherapeutically induced cutaneous tuberculosis after BCG injection in a patient with pelvic osteosarcoma. (2012) (2)
Updating the lipids hypothesis of inflammation and vascular disease in patients with chronic kidney disease: a stearoyl‐CoA desaturase affair? (2013) (2)
Albuminuria in the normal range: the lower is not the better. (2013) (2)
MO729LUNG ULTRASOUND GUIDED DRY-WEIGHT REDUCTION DECREASES CARDIAC CHAMBERS DIMENSIONS AND IMPROVES VENTRICULAR DIASTOLIC FUNCTION IN HEMODIALYSIS PATIENTS: LONG-TERM ANALYSIS OF A LUST SUB-STUDY (2021) (2)
Should we extend the application of more frequent dialysis schedules? A 'yes' and a hopeful 'no'. (2015) (2)
Sodium and cardiovascular disease (2016) (2)
Atherosclerosis and the Glu 298 Asp Polymorphism of the eNOS Gene in White Patients With End-Stage Renal Disease (2005) (2)
Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study (2020) (2)
Arterial Stiffness as a Cardiovascular Risk Factor in Stage 5D Chronic Kidney Disease Patients: An Age Affair (2016) (2)
[Oscillometric wrist devices: comparison with the standard mercury sphygmomanometer and estimate of the "supine" error]. (2003) (2)
Chronic kidney disease certification process manual by the Italian Society of Nephrology (SIN): part II: programme management and clinical information management. (2009) (2)
Cocoa Flavanols: A Magic Potion for Protecting the Endothelium in Kidney Failure? (2016) (2)
Effect of furosemide on renal size: ultrasonic characterization of renovascular hypertension. (1982) (2)
[Spinal cord infarction during haemodialysis]. (2003) (2)
Endothelial dysfunction in subcutaneous small resistance arteries and cardiovascular events. (2006) (2)
Thyroid, Renal Function, and Cardiac Outcome (2009) (2)
Ambulatory monitoring and clinic BP measurements for predicting left ventricular mass in patients with chronic renal diseases. (1999) (2)
Pharmacoepidemiology for nephrologists (part 1): concept, applications and considerations for study design (2020) (2)
Obesity and Kidney Disease: Hidden Consequences of the Epidemic. (2017) (2)
[Cox regression analysis in epidemiological research]. (2011) (2)
[Cardiovascular events in chronic advanced renal insufficiency. Current concepts]. (2003) (2)
A new technique to perform pelvic osteotomy using Gigli saw (2013) (2)
Obesity and kidney disease: hidden consequences of the epidemic (2017) (2)
Noncardiogenic pulmonary edema induced by hydrochlorothiazide. (2010) (2)
Epidemiology of hyperkalemia in CKD patients under nephrological care: a longitudinal study (2021) (2)
Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe (2019) (2)
Do we still need cross‐sectional studies in Nephrology? Yes we do!: Clinical Epidemiology in Nephrology (2017) (2)
MP305THE EVOLUTION OF QUALITY OF LIFE (QoL) OVER TIME IN CHRONIC KIDNEY DISEASE PATIENTS (CKD): PERCEPTION OF GENERAL HEALTH BUT NO OTHER QoL- DIMENSION DECLINES OVER THE COURSE OF CKD (2016) (2)
Chronic hemodynamic effects of propranolol treatment in dialysis-refractory hypertension. (1978) (2)
[Italian adaptation of the European Renal Best Practice (ERBP) guideline on kidney donor and recipient evaluation and perioperative care]. (2014) (2)
Background Dietary Patterns and the Time Course of the Blood Pressure Response to Low Sodium Intake. (2017) (2)
Physical functioning and mortality in very old patients on dialysis. (2019) (2)
NDT Perspectives Graphical presentation of confounding in directed acyclic graphs (2015) (2)
Simplifying volume assessment with lung ultrasound in paediatric haemodialysis patients (2020) (2)
Faculty Opinions recommendation of Fibroblast growth factor-23 and cardiovascular events in CKD. (2014) (2)
Surgery: Treatment of Oligometastatic Disease (2017) (2)
Obesity and kidney disease: hidden consequences of the epidemic. (2017) (2)
A New Proximal Femur Reconstruction Technique after Bone Tumor Resection in a Very Small Patient: An Exemplificative Case (2021) (2)
Faculty Opinions recommendation of SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. (2020) (2)
Obesity and kidney disease: Hidden consequences of the epidemic. (2017) (2)
Author Correction: Lipid management in patients with chronic kidney disease (2018) (2)
Further approaches to reduce the cost of renal replacement therapy (2017) (2)
Guest Editor: Rajiv Agarwal: Cardiovascular Risk Profile Assessment and Medication Control Should Come First (2007) (2)
Epidemiology and outcome - 1 (2009) (2)
A greenstick osteoporotic tibial fracture while on chemotherapy in a 12-year-old girl with osteosarcoma of the knee: does a preventive role exist for agents that reduce iatrogenic bone loss and skeletal-related events? (2011) (2)
The First European Renal Association-European Dialysis and Transplant Association CKD Anaemia Physician Behaviours Survey: key findings. (2008) (2)
SO089THE EVOLUTION OF THE RENAL FUNCTION IN A COHORT OF ITALIAN PATIENTS WITH ADPKD: AN ANALYSIS BY THE JOINT MODEL (2020) (2)
Faculty Opinions recommendation of Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. (2019) (2)
Nutrition and inflammation (2013) (2)
Treatment strategies for chronic renal failure : limitations of resources and prioritites : the dilemma of the Nineties (1994) (2)
Brain dysfunction in tubular and tubulointerstitial kidney diseases (2021) (2)
A milestone paper in clinical dialysis. A half century celebration. (2011) (2)
Vitamin D receptor activation by paricalcitol and insulin resistance in CKD. (2017) (2)
Cholesterol: Another Salty Pathway to Cardiovascular Disease? (2017) (2)
Does asymmetric dimethylarginine play a role in depression in chronic kidney disease patients? (2015) (1)
Life-Time Risk, Screening and The Cost of Cardiovascular Comorbidities in CKD Patients (2015) (1)
Dry Mouth in Dialysis Patients (1994) (1)
Smoking and hyperparathyroidism in patients with end-stage renal disease (ESRD). (2012) (1)
INNATE IMMUNITY AND CKD PROGRESSION (2012) (1)
Protein-energy wasting (2013) (1)
SP265HIGH SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS A STRONG , INDEPENDENT PREDICTOR OF THE RISK OF WORSENING PROTEINURIA AND CKD PROGRESSION IN STAGE 2-5 CKD PATIENTS (2016) (1)
EARLY MORNING HEMODYNAMIC CHANGES AND LEFT VENTRICULAR HYPERTROPHY AND MORTALITY IN HEMODIALYSIS PATIENTS (2022) (1)
Long-Term Effect of Physical Exercise on the Risk for Hospitalization and Death in Dialysis Patients (2022) (1)
Nephrology in the clinic and quality in nephrology. (2003) (1)
The cardiovascular-renal link and the health burden of kidney failure. (2023) (1)
Lung ultrasound guided dry-weight reduction and echocardiographic changes in clinically euvolemic hypertensive hemodialysis patients: 12-month results of a randomized controlled trial (2021) (1)
Adolescent Scoliosis 1A001: Radiographic Results of Selecting the Touched Vertebra as the Lowest Instrumented Vertebra in Lenke Type 1 (Main Thoracic) & Type 2 (Double Thoracic) Curves at a Minimum 5-year Follow-up (2017) (1)
Osteoid osteoma of the proximal phalanx of the hallux: a case report of a challenging diagnosis (2020) (1)
[Prevention of chronic renal disease: a key issue of the nephrology mission]. (2008) (1)
Obestatin, a Ghrelin-Cognate Protein, and Clinical Outcomes in Hemodialysis Patients (2018) (1)
SO017DISORDERED SLEEP BREATHING IS THE MAJOR DETERMINANT OF NON-DIPPING AND NOCTURNAL HYPERTENSION IN TRANSPLANT PATIENTS (2016) (1)
ENALAPRIL (MK421) AND MK521 - A COMPARISON IN NORMAL SUBJECTS (1984) (1)
[Xerostomia and Xerophthalmia in haemodialysis patients]. (2002) (1)
Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in CKD: translational opportunities and challenges (1)
The oscillometric wrist devices: an estimate of the ‘supine’ error (2002) (1)
Reconstruction after musculoskeletal sarcomas: how to avoid a surgical trap. (2016) (1)
The alarm reaction to blood pressure measurement in dialysis patients. (1996) (1)
Prognostic values of left ventricular mass index in chronic kidney disease patients (2020) (1)
CKD GENERAL AND CLINICAL EPIDEMIOLOGY 2 (2014) (1)
SALT INTAKE AND INFLAMMATION IN ESSENTIAL HYPERTENSION: 1B.05 (2010) (1)
Thiazide diuretics are back in CKD: the case of chlorthalidone (2022) (1)
Minimal cognitive impairment and kidney disease : clinical aspects (2019) (1)
The giant aggressive chondroma: A rare entity, a difficult approach. (2020) (1)
Hypertension and cardiovascular risk in chronic kidney disease. (2012) (1)
Moderator's view: renal denervation: the jury is still out and the verdict will be more complex than initially envisaged. (2014) (1)
Failure of AVP and other pressor hormones to increase in severe recurrent dialysis hypotension. (1996) (1)
Erratum to: Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment (2022) (1)
FP720SLEEP DISORDERED BREATHING IN RENAL TRANSPLANT PATIENTS: A LONGITUDINAL STUDY (2018) (1)
Does a vitamin D boost help in resistant hypertension control? (2014) (1)
International differences in CKD prevalence . A key public health and epidemiologic research issue (2016) (1)
Clinical Nephrology - Epidemiology I (2012) (1)
Enalapril (MK421) anditslysine analogue (MK521): A com- parison ofacute andchronic effects onblood pressure, renin- angiotensin system andsodium excretion innormal man (1984) (1)
A new therapy for sleep apnea? (2021) (1)
[The relationship between the heart and the kidney in acute heart failure: doubts of the cardiologist and the nephrologist's point of view]. (2012) (1)
A Comparison of Antibiotic Release between a Cement Scaffold, a Perforated Cement Scaffold and a Cement Scaffold Mixed to Calcium Sulphate: In vitro Study (2011) (1)
Obesity and kidney disease: Hidden consequences of the epidemic. (2017) (1)
Subject Index, Vol. 63, 1993 (1993) (1)
[Hypertension in dialysis patients. Italian Guidelines]. (2006) (1)
Erratum to Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials (2019) (1)
Elimination of plasma metenkephalin. (1989) (1)
Salt intake correlates with night systolic blood pressure in non-dialytic chronic kidney disease. (2022) (1)
Clinical nephrology - miscellaneous (2013) (1)
Salt, resting arterial pressure and 24 h monitoring. (1997) (1)
The chronology of the clinical cardio renal links and health outcomes. (2022) (1)
HCV and renal disease: not always associated with mixed cryoglobulinemia. (2003) (1)
Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients. (1982) (1)
Oxidized LDL, Gamma‐Glutamyltransferase and Adverse Outcomes in Older Adults (2017) (1)
The role of minimally invasive plate osteosynthesis (MIPO) technique for treating 3- and 4-part proximal humerus fractures in the elderly. A case study (2021) (1)
A computer-assisted navigation technique to perform bone tumor resection without dedicated software (2016) (1)
Is Metenkephalin responsible for the baroreflex dysfunction of chronic uraemics? (1984) (1)
Hepatocyte growth factor and cardiomyopathy in dialysis patients. (2012) (1)
Age, stage and biomarkers for the definition of CKD: a construction in progress (2013) (1)
The Dilemma of Making Recommendations Based on Weak Evidence (2011) (1)
Low triiodothyronine: a pathway to coronary calcification in patients maintained on peritoneal dialysis (2013) (1)
[Nephropathy associated with arterial hypertension: genes and Barker's hypothesis]. (2002) (1)
The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council (2018) (1)
Low triiodothyronine and cardiovascular disease. (2003) (1)
Safety of non-vitamin K antagonist oral anticoagulants: concerns in patients with atrial fibrillation and glomerular hyperfiltration? (2022) (1)
Custom Massive Allograft in a Case of Pelvic Bone Tumour: Simulation of Processing with Computerised Numerical Control vs. Robotic Machining (2022) (1)
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey (2021) (1)
Erratum: Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe (Nephrology Dialysis Transplantation (2019) (gfz089) DOI: 10.1093/NDT/gfz089) (2019) (1)
The use of engineered biomaterial Bone Plexur M® in benign epiphyseal tumors: our experience at 20 months of follow-up. (2014) (1)
FP238THE WNT/β-catenin PATHWAY IN THE NEPHROTIC SYNDROME SCENARIO (2019) (1)
Effectiveness of Cold Hemodialysis (HD) for the Prevention of HD Hypotension and Mortality in the General HD Population. (2023) (1)
The risk for chronic kidney disease in metabolically healthy obese patients: A systematic review and meta‐analysis (2022) (1)
The legacy effect of a home walking exercise program in kidney failure patients on dialysis. (2022) (1)
Another Marker of Cardiac Dysfunction in Dialysis Patients? (2003) (1)
Does ambulatory monitoring make saltier salt sensitivity studies? (1997) (1)
SP366CLINICAL PHENOTYPE OF ADPKD PATIENTS AT THE TIME OF REFERRAL TO NEPHROLOGISTS: A MULTICENTER SURVEY IN ITALY (2015) (1)
THE EFFECT OF DRY-WEIGHT REDUCTION GUIDED BY LUNG ULTRASOUND ON AMBULATORY BLOOD PRESSURE IN HEMODIALYSIS PATIENTS (2019) (1)
Hypokalaemic Hypertension due to a Nasal Spray containing 9α Fluoroprednisolone (1984) (1)
European guidelines on when to start dialysis: check the facts first before commenting. (2012) (1)
4A.04: EFFECTS OF RENAL DENERVATION ON ASYMMETRIC DIMETHYLARGININE AND SYMPATHETIC NERVE TRAFFIC IN RESISTANT HYPERTENSIVE PATIENTS (2015) (1)
Validation and Evaluation of Memorial Symptom Assessment Scale Short-Form (Msas-Sf)In a Romanian Cohort of Hemodialysis Patients (2015) (1)
Epidemiology - cardiovascular outcomes (2013) (1)
FP690APPARENT TREATMENT-RESISTANT HYPERTENSION IN THE HEMODIALYSIS POPULATION: AN AMBULATORY BP MONITORING (ABPM) BASED STUDY (2019) (1)
Influence of extracellular volume expansion on circulating PTH1-84 in subjects with mild essential hypertension. (1994) (1)
An osteoporotic hip fracture in a 14-year-old girl undergoing chemotherapy and operated for knee osteosarcoma (2009) (1)
Urotensin in ESRD: not so surprising. (2006) (1)
Erratum: Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: A study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA (Nephrology Dialysis Transplantation (2018) (gfy147) DOI: 10.1093/NDT/gfy147) (2018) (1)
Hypotensive effect of ultra-low sodium dialysate in CAPD patients A double-blind, randomized, crossover study (1998) (1)
Disease Patients Left Ventricular Systolic Dysfunction: A Sudden Killer in End-Stage Renal (2010) (0)
[PP.23.16] TIME INTEGRATED SYMPATHETIC ACTIVITY CHANGES PARALLEL SIMULTANEOUS BP CHANGES AFTER RENAL DENERVATION (2016) (0)
MO500A NEW INDEX BASED ON THE DIFFERENCE BETWEEN CREATININE-BASED EGFR AND CYSTATIN-C EGFR ASSOCIATES WITH THE PHYSICAL COMPONENT OF THE SF-36 AND PREDICTS CARDIOVASCULAR EVENTS AND PROGRESION TO KIDNEY FAILURE IN CKD (2021) (0)
[PP.07.30] AMBULATORY PULSE WAVE VELOCITY AND AUGMENTATION INDEX PREDICT CARDIOVASCULAR EVENTS AND ALL-CAUSE MORTALITY BETTER THAN OFFICE AND AMBULATORY BLOOD PRESSURE IN HEMODIALYSIS PATIENT (2017) (0)
THE EFFECTOFA 5-HTANTAGONIST,KETANSERIN,ON BLOOD PRESSURE,THERENIN-ANGIOTENSIN SYSTEMAND SYMPATHO- ADRENAL FUNCTIONINNORMAL MAN (1983) (0)
Title Page / Contents / New and Old Dilemmas in Nephrology (1994) (0)
EVALUATION OF INTRAVENOUS NACl LOAD AS A TEST OF SALT SENSITIVITY IN ESSENTIAL HYPERTENSIVE PATIENTS: P2.146 (2000) (0)
NDT on the move: an editorial note by the Editor-in-Chief for Portuguese nephrologists (2012) (0)
TO003A GENETIC BIOMARKER OF OXIDATIVE STRESS, THE PARAOXONASE-1 Q192R GENE VARIANT, ASSOCIATES WITH CARDIOMYOPATHY IN CKD: A LONGITUDINAL STUDY (2016) (0)
SP052THE STUDY OF ENDOTHELIAL FUNCTION IN CKD: IS DIGITAL PLETHYSMOGRAPHY A RELIABLE SURROGATE OF FLOW MEDIATED VASODILATION IN THE BRACHIAL ARTERY IN THE FOREARM? (2017) (0)
SP581POOR PHYSICAL PERFORMANCE IN HEMODIALYSIS PATIENTS CAPTURES AN INCREASINGLY HIGHER PREDICTIVE POWER FOR MORTALITY ACROSS PROGRESSIVE AGE-STRATA (2016) (0)
A new series of advanced-level research methods papers (2020) (0)
Faculty Opinions recommendation of Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-contro (2019) (0)
5.1 Cardiac Natriuretic Peptides Reflect Left Atrial Volume (LAV) and Capture Longitudinal Changes in LAV in End-Stage Renal Disease Patients (2008) (0)
Faculty Opinions recommendation of Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study). (2009) (0)
SO049THE NATURE OF THE ASSOCIATION BETWEEN FGF23 AND MORTALITY AND CARDIOVASCULAR DISEASE IN END STAGE KIDNEY DISEASE PATIENTS: A MENDELIAN RANDOMIZATION STUDY (2017) (0)
Effect of vitamin D supplementation on markers of vascular function (2018) (0)
Studio SIR-SIN (Studio italiano Indicatori di Risultato multipli - Epidemiologia dell'IRC in Italia) della Societa Italiana di Nefrologia nella popolazione affetta da IRC in terapia conservativa. Dati preliminari. (2006) (0)
Cardiorenal Syndrome and Hypertensive Heart Disease(State-of-the-Art, Cardiorenal Syndrome and Hypertensive Heart Diseases, The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
P1394ASSOCIATION BETWEEN PARATHYROID HORMONE AND MORTALITY IN HAEMODIALYSIS: THE DIABETES MAKES THE DIFFERENCE (2020) (0)
Hypertension in end-stage renal disease: target values, methods of measurement and drug therapy. (2002) (0)
In reply to Król (2002) (0)
SP322ADIPONECTIN MODIFIES THE FGF23 RESPONSE TO VITAMIN D RECEPTOR ACTIVATION: A RANDOMIZED CLINICAL TRIAL (2018) (0)
[Multiple reuse of the capillary kidney by washing with 0.25 M NaOH]. (1975) (0)
Is silent cerebral infarction associated with vascular events in patients undergoing hemodialysis? (2006) (0)
The expanding uraemic population. A southern European perspective. (1994) (0)
Faculty Opinions recommendation of Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. (2007) (0)
SALT INTAKE AND HYPERFILTRATION. AUTHOR'S REPLY (1996) (0)
THE NOVEL FIBROSIS MARKER GALECTIN 3 ASSOCIATES WITH INFECTIOUS DEATHS , ALL-CAUSEMORTALITY AND CARDIOVASCULAR EVENTS IN HEMODIALYSIS PATIENTS (2013) (0)
FP563CLINICAL EPIDEMIOLOGY OF SYSTOLIC AND DIASTOLIC ORTHOSTATIC HYPOTENSION IN PATIENTS ON PERITONEAL DIALYSIS (2019) (0)
SP266NEUROPEPTIDE Y ASSOCIATES WITH GFR LOSS AND PROTEINURIA AND PREDICTS THE EVOLUTION OF CKD TOWARD KIDNEY FAILURE: A STUDY IN TWO EUROPEAN CKD COHORTS (2017) (0)
[The Italian nephrology network: findings and indications of the Italian Society of Nephrology (SIN)]. (2008) (0)
8.4 Circulating Levels of E-Selectin are Inversely Related to Left Ventricular Wall Thickness in Patients on Regular Dialysis (2008) (0)
Points of attention when conducting etiological research (2021) (0)
Thyroid Dysfunction and Cardiovascular Disease in Chronic Kidney Disease (2020) (0)
Faculty Opinions recommendation of Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis. (2021) (0)
[Autonomic disorders in uremia]. (1990) (0)
SaO019LUNG ULTRASOUND GUIDED DRY-WEIGHT PROBING REDUCES CARDIAC CHAMBERS DIMENSIONS AND LEFT VENTRICULAR FILLING PRESSURES IN HEMODIALYSIS PATIENTS WITH HYPERTENSION (2019) (0)
Lab methods, progression & risk factors for CKD - 3 (2009) (0)
An unusual case of osteomyelitis of IV metacarpus mimicking osteosarcoma (2008) (0)
Prognostic Value of 24H Ambulatory Blood Pressure Monitoring in a Large, Low Risk Cohort of Haemodialysis Patients: 1.1 (2005) (0)
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal syndrome]. (2022) (0)
SP012A POLYMORPHISM IN THE SIRT-1 GENE ASSOCIATES WITH CONCENTRIC REMODELLING OF THE LEFT VENTRICLE AND PREDICTS THE LONGITUDINAL EVOLUTION OF THIS ALTERATION BOTH IN STAGE G1-5 CKD PATIENTS AND IN DIALYSIS PATIENTS (2018) (0)
[Functional relationships between plasma renin activity and hemodynamic indices in essential arterial hypertension]. (1980) (0)
FO080APABETALONE, AN INHIBITOR OF BET PROTEINS, IMPROVES CARDIOVASCULAR RISK AND REDUCES ALKALINE PHOSPHATASE IN BOTH CVD PATIENTS AND PRIMARY HUMAN CELL CULTURE SYSTEMS (2019) (0)
Propranolol in hyper reninemic malignant hypertension a hemodynamic study (1977) (0)
The location of adipose tissue is important: epicardial fat in patients with chronic kidney disease (2015) (0)
FP297IS THE CARDIORENAL LINK BIDIRECTIONAL IN CKD PATIENTS?: A LONGITUDINAL STUDY (2018) (0)
Contents Vol. 118, 2011 (2011) (0)
[Modelling binary outcomes in clinical research]. (2011) (0)
Contents Vol. 36, 2013 (2014) (0)
Faculty Opinions recommendation of Management of Coronary Disease in Patients with Advanced Kidney Disease. (2020) (0)
What's new at the ERA-EDTA Registry? (2008) (0)
FP330APABETALONE, A SELECTIVE BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, REDUCES SERUM FGF23 IN CARDIOVASCULAR DISEASE AND CHRONIC KIDNEY DISEASE PATIENTS (2019) (0)
Contents Vol. 39, 2014 (2014) (0)
DIALYSIS. EPIDEMIOLOGY, OUTCOME RESEARCH, HEALTH SERVICES 1 (2014) (0)
FP635LOW KT/V AMPLIFIES THE PRESSOR EFFECT OF EXTRACELLULAR VOLUME EXPANSION IN HEMODIALYSIS PATIENTS (2018) (0)
Author Index/Subject Index Proceedings (2002) (0)
[In memory of Bruno Cianciaruso]. (2013) (0)
[Microhematuria. Prevalence, test validity and clinical usefulness]. (2004) (0)
Translational research in nephrology: prognosis (2021) (0)
FP633PULSE WAVE VELOCITY AND PROGNOSIS IN CHRONIC KIDNEY FAILURE (2018) (0)
MO891: Poor Tolerability of the Standard, Extended, 48h Ambulatory Blood Pressure Monitoring in Haemodialysis Patients (2022) (0)
Faculty Opinions recommendation of Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. (2009) (0)
Faculty Opinions recommendation of Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. (2020) (0)
EARLY MORNING HEMODYNAMIC CHANGES AND LEFT VENTRICULAR HYPERTROPHY AND MORTALITY IN HEMODIALYSIS PATIENTS. (2022) (0)
The non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with high-normal renal function - A systematic review. (2022) (0)
FP379ERYTHROFERRONE PREDICTS MORTALITY AND CARDIOVASCULAR EVENTS IN CKD AND IN HEMODIALYSIS PATIENTS: A TWO COHORTS STUDY (2019) (0)
The Real-Life Journey of Elderly Patients in Soft Tissue and Bone Sarcomas: A Retrospective Analysis from a Sarcoma Referral Center (2020) (0)
Metabolomic markers mediate erythrocyte anisocytosis in older adults: Results from three independent aging cohorts (2023) (0)
Contents Vol. 40, No. 4, 2015 (2015) (0)
CKDにおける心筋症に伴う,酸化ストレスの遺伝学的バイオマーカー,パラオキソナーゼQ192R遺伝子バリアント (2016) (0)
Full Reviews Definition, identification and treatment of resistant hypertension in chronic kidney disease patients (2014) (0)
Faculty Opinions recommendation of A wearable haemodialysis device for patients with end-stage renal failure: a pilot study. (2008) (0)
PP.02.10: A GENETIC MARKER OF HYPERURICEMIA PREDICTS CARDIOVASCULAR EVENTS IN A META-ANALYSIS OF THREE COHORT STUDIES IN HIGH RISK PATIENTS (2015) (0)
Donor obesity and weight gain after transplantation: two still overlooked threats to long-term graft survival (2022) (0)
Contents Vol. 113, 2009 (2009) (0)
CKD PATHOPHYSIOLOGY AND CLINICAL STUDIES (2014) (0)
Modalità di stima del filtrato glomerulare (FG) e inizio della dialisi. Dati preliminari dello studio SIR-SIN (Studio italiano Indicatori di Risultato multipli - Epidemiologia dell'IRC in Italia) della Societa Italiana di Nefrologia nella popolazione affetta da IRC in terapia conservativa (2006) (0)
MP044CAN GENETIC RISK SCORES IMPROVE THE PREDICTON POWER FOR MORTALITY OF STANDARD RISK FACTORS IN THE END STAGE KIDNEY DISEASE POPULATION? AN EXPLORATORY STUDY (2016) (0)
4308Lung ultrasound guided dry-weight probing reduces left and right atrial dimensions and left ventricular filling pressures in hemodialysis patients with hypertension (2019) (0)
[The PATHWAY-2 study]. (2016) (0)
Faculty Opinions recommendation of The effect of tolvaptan on BP in polycystic kidney disease: A post hoc analysis of the TEMPO 3:4 trial. (2021) (0)
When comparing the safety of drugs, don't forget the exposure dimension (2023) (0)
Subject Index Vol. 116, 2010 (2010) (0)
Innate Immunity System in Patients With Cardiovascular and Kidney Disease (2023) (0)
Mineral and bone disease - CKD 1-5 (2012) (0)
[Pathogenesis of renal failure in hypertension. The role of genetic factors, low weight at birth and endothelial dysfunction]. (2005) (0)
FC 079HIGH SERUM PHOSPHATE, A NOVEL POTENTIAL RISK FACTOR FOR BONE FRAGILITY FRACTURES IN THE COSMOS STUDY (2021) (0)
Epidemiology - renal outcomes (2013) (0)
Faculty Opinions recommendation of Effects of Allopurinol on the Progression of Chronic Kidney Disease. (2020) (0)
Faculty Opinions recommendation of Hemodialysis with Cohort Isolation to Prevent Secondary Transmission during a COVID-19 Outbreak in Korea. (2020) (0)
Epidemiology & outcome in CKD 5D (1) (2011) (0)
The pharmacokinetics of antidepressants for depression in stage 3 to 5 chronic kidney disease: A systematic review by European Renal Best Practice (ERBP) (2011) (0)
Acknowledgments (2017) (0)
APPARENT TREATMENT-RESISTANT HYPERTENSION IN THE HEMODIALYSIS POPULATION (2019) (0)
6.9 Circulating E-Selectin is a Marker of Risk and Interacts with Inflammation in Dialysis Patients (2007) (0)
16th International Conference on Dialysis. Advances in Chronic Kidney Disease 2014. January 22-25, 2014, Caesars Palace, Las Vegas, Nev.: Abstracts (2013) (0)
A LONGITUDINAL, LONG TERM, ANALYSIS OF SLEEP DISORDERED BREATHING IN RENAL TRANSPLANT PATIENTS (2019) (0)
Progression & risk factors CKD 1-5 (1) (2011) (0)
MO841EFFICACY OF PHYSICAL EXERCISE IN PERITONEAL DIALYSIS PATIENTS: A SECONDARY ANALYSIS OF THE EXCITE TRIAL (2021) (0)
Faculty Opinions recommendation of Pharmacological Npt2a Inhibition Causes Phosphaturia and Reduces Plasma Phosphate in Mice with Normal and Reduced Kidney Function. (2019) (0)
Subject Index Vol. 32, 2010 (2010) (0)
MO870: The Legacy Effect of a Home Walking Exercise Program in Kidney Failure Patients on Dialysis (2022) (0)
Contents, Vol. 65, 1993 (1993) (0)
Faculty Opinions recommendation of Cystatin C as a risk factor for outcomes in chronic kidney disease. (2007) (0)
P1442CAN THE ASSESSMENT OF ULTRASOUND LUNG WATER IN HEMODIALYSIS PATIENTS BE SIMPLIFIED? (2020) (0)
Bone disease in CKD 1-5 (2011) (0)
Epidemiology and CKD - 2 (2009) (0)
PP.11.22: RATE OF GFR FALL OVER TIME, 24H AMBULATORY BP MONITORING AND OFFICE BP IN TRANSPLANT PATIENTS (2015) (0)
Author Index to Abstracts (2002) (0)
Acknowledgement of Reviewers (2008) (0)
Faculty Opinions recommendation of Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. (2020) (0)
SP725CYCLOPHILLIN A PREDICTS THE RATE OF GFR LOSS AND REPEATED CYCLOPHILLIN MEASUREMENTS OVER TIME CORRELATE WITH SIMULTANEOUS GFR MEASUREMENTS IN LONGITUDINAL ANALYSES IN RENAL TRANSPLANT PATIENTS (2019) (0)
Extrapolated normative GFR data for living kidney donation (2022) (0)
Low Grade Chondrosarcoma: what is the best treatment? A review of literature and personal opinion (2014) (0)
A six months low intensity home-based walking program prevents respiratory muscle impairment in dialysis patients: The EXCITE study (2012) (0)
The need for a multi-disciplinary reflection about frailty and cognitive impairment in chronic kidney disease (2022) (0)
SP222CKD 273 CLASSIFIER AS EARLY MARKER FOR TUBULOINTERSTITIAL FIBROSIS (2016) (0)
Faculty Opinions recommendation of A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus. (2019) (0)
Global approach to cardiovascular (CV) risk in chronic kidney disease (CKD) stage III-V: reality and opportunities for intervention. ASN Renal Week 2004. St. Luis, 27 October-1 November 2004.JASN 2004;15:314A. (2006) (0)
Present and future of CONNECT: a new and compelling project of modern medicine (2021) (0)
OP-NDTJ200267 1..8 (2020) (0)
General & clinical epidemiology CKD 1-5 (1) (2011) (0)
Faculty Opinions recommendation of Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participants. (2021) (0)
SLEEP DISORDERED BREATHING (SDB) REEMERGENCE AND SYSTEMIC HYPERTENSION IN RENAL TRANSPLANT PATIENTS (2019) (0)
Faculty Opinions recommendation of Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. (2021) (0)
Survival with low- and high-flux dialysis (2020) (0)
Obesity and kidney disease: Hidden consequences of the epidemic. (2017) (0)
Osteoblastoma: When the Treatment Is Not Minimally Invasive, an Overview (2021) (0)
Attualità sulla patogenesi dell'insufficienza renale nell'ipertensione. Il ruolo dei fattori genetici, del basso peso alla nascita e della disfunzione endoteliale (2005) (0)
Erratum to: The quality of reporting in clinical research: the CONSORT and STROBE initiatives (2013) (0)
SLEEP DISORDERED BREATHING IN RENAL TRANSPLANT PATIENTS: A LONGITUDINAL STUDY (2018) (0)
FP719 CLINICAL IMPLICATIONS OF URINARY CELL-FREE MITOCHONDRIAL DNA LEVEL EARLY AFTER KIDNEY TRANSPLANTATION (2018) (0)
P2640The effect of dry-weight reduction guided by lung ultrasound on ambulatory aortic blood pressure and arterial stiffness parameters in hemodialysis patients (2019) (0)
F1000Prime recommendation of CKD: A Call for an Age-Adapted Definition. (2019) (0)
Consultants for the American Journal of Nephrology 2010 (2010) (0)
Monday, July 17, 2006 New biomarkers and therapeutic strategies of cardiovascular events in the renal patient iv297 (2006) (0)
Transplantation: clinical studies - A (2013) (0)
Cardiovascular complications in CKD 5D (1) (2011) (0)
Clinical epidemiology and CKD 1-5 (2012) (0)
Original Articles Instrumental variable analysis (2013) (0)
FP393LEFT VENTRICULAR MASS INDEX AS A PROGNOSTIC PARAMETER IN CHRONIC KIDNEY DISEASE PATIENTS (2019) (0)
Faculty of 1000 evaluation for Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout. (2018) (0)
Faculty Opinions recommendation of Empagliflozin and progression of kidney disease in type 2 diabetes. (2016) (0)
Farewell Editorial. (2017) (0)
OP-NDTP180065 437..442 (2018) (0)
Novel Therapeutic Options for Cardiovascular Disease with CKD. (2021) (0)
MO499CKD-MBD BIOMARKERS AND CKD PROGRESSION: AN ANALYSIS BY JOINT MODELS (2021) (0)
Short-Segment Versus Long-Segment Stabilization in Thoracolumbar Burst Fracture: A Review of the Literature (2017) (0)
Asymmetric dimethylarginine predicts survival in the elderly (2013) (0)
Pharmacokinetic relevance of glomerular hyperfiltration for drug dosing (2023) (0)
Contents Vol. 43, 2017 (2017) (0)
TRANSLATIONAL CKD RESEARCH (2014) (0)
Wide surgery in the cervical spine: indications, results and complications in a series of 30 patients affected by primary bone tumors. (2021) (0)
Faculty Opinions recommendation of Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial. (2019) (0)
Coronary artery calcification progression and long-term cardiovascular outcomes in renal transplant recipients: an analysis by the joint model (2021) (0)
F1000Prime recommendation of Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. (2009) (0)
Faculty Opinions recommendation of Effect of intensive urate lowering with combined verinurad and febuxostat on albuminuria in patients with type 2 diabetes: A randomized trial. (2021) (0)
MO858: Early Morning Haemodynamic Changes and Left Ventricular Hypertrophy and Mortality In Haemodialysis Patients (2022) (0)
P0824QUALITY OF LIFE (QOL) DURING THE COURSE OF CKD: A LONGITUDINAL STUDY (2020) (0)
Faculty Opinions recommendation of Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. (2020) (0)
Faculty Opinions recommendation of Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. (2008) (0)
MO102LUNG ULTRASOUND-GUIDED DRY-WEIGHT REDUCTION DECREASES AMBULATORY BLOOD PRESSURE LEVELS IN HYPERTENSIVE HEMODIALYSIS PATIENTS: LONG-TERM ANALYSIS OF A LUST SUB-STUDY* (2021) (0)
CKD / Human studies (2011) (0)
Lo studio PATHWAY-2 (2016) (0)
Hypokalaemic hypertension due to a nasal spray containing 9 alpha fluoroprednisolone. (1984) (0)
FP682SYSTEMIC INFLAMMATION INTERACTS WITH LEFT VENTRICULAR PRESSURE IN DETERMINING LUNG CONGESTION SEVERITY IN HAEMODIALYSIS PATIENTS (2019) (0)
Chapter 11 – Dietary Modulation of the Inflammatory Response (2008) (0)
Title Page / Contents / Clinical and Basic Science in Nephrology and Hypertension (1996) (0)
[The "new nephrology," reality and hope: results of an analysis]. (2007) (0)
[Measures of frequency in epidemiology studies: incidence and prevalence]. (2010) (0)
24HABPM IN THE LONG TERM FOLLOW UP OF RENAL TRANSPLANT PATIENTS: FOCUS ON AN UNMET CLINICAL NEED (2018) (0)
An evidence-based nephrology column in the JN. (1999) (0)
SP831RATE OF GFR FALL OVER TIME, 24H AMBULATORY BP MONITORING AND OFFICE BP IN TRANSPLANT PATIENTS (2015) (0)
THE INTERACTION BETWEEN ENOS AND CAVEOLIN-1 GENE POLYMORPHISMS IN ESRD PATIENTS: A PROOF OF CONCEPT STUDY: PP.20.128 (2011) (0)
Relationship between left ventricular mass, uremia, hypertension and vagal tachycardic reserve. (2003) (0)
THE EFFECT OF DRY-WEIGHT REDUCTION GUIDED BY LUNG ULTRASOUND ON AMBULATORY AORTIC BLOOD PRESSURE AND ARTERIAL STIFFNESS PARAMETERS IN HEMODIALYSIS PATIENTS (2019) (0)
Faculty Opinions recommendation of Diagnostic utility of exome sequencing for kidney disease. (2019) (0)
Subject Index, Vol. 65, 1993 (1993) (0)
Arthroplasty-CervicalP001 - Double Crush Syndrome of the Vertebral Artery Loop and Foraminal Stenosis Causing Monoparesis (2017) (0)
Sodium, Potassium, and Hydrogen Ions in Chronic Renal Failure (1989) (0)
Contents, Vol. 56, 1990 (1990) (0)
2.12 Left Atrial Volume is a Relevant Predictor of Cardiovascular Outcomes in Dialysis Patients (2007) (0)
Hypertension in Dialysis Patients: Clinical Epidemiology, Pathogenesis, Diagnosis, and Treatment (2018) (0)
[Continuous medical education]. (2004) (0)
NUTRITION AND INFLAMMATION TO027 LONGITUDINAL PREDICTORS OF C-REACTIVE PROTEIN IN HEMODIALYSIS PATIENTS: RESULTS FROM THEMONDO INITIATIVE (2013) (0)
MP326SHORT-TERM VARIABILITY DOES NOT PREDICT CARDIOVASCULAR OUTCOME IN NON-DIALYSIS CKD PATIENTS (2016) (0)
a Broad Spectrum of Patients With Heart Failure'' Letter by Kielstein et al Regarding Article, ''Renal Function as a Predictor of Outcome in (2012) (0)
LUNG ULTRASOUND GUIDED DRY-WEIGHT PROBING REDUCES CARDIAC CHAMBERS DIMENSIONS AND LEFT VENTRICULAR FILLING PRESSURES IN HEMODIALYSIS PATIENTS WITH HYPERTENSION (2019) (0)
[Vasoconstriction-volume bipolar analysis of arterial hypertension. Hemodynamic verification]. (1979) (0)
Evaluation of renal function in a cohort of patients affected by obstructive sleep apnea (2012) (0)
The new NDT series Ideas, Conjectures and Refutations (ICR): elegance in nephrology research. (2013) (0)
UvA-DARE ( Digital Academic Repository ) Epidemiology of chronic kidney disease in Europe Brück (2016) (0)
Undernutrition in childhood and adolescence and atherosclerosis in adult life. (2020) (0)
[OP.1A.02] INNATE IMMUNITY AND CARDIO-RENAL RISK IN STAGE 2-5 CKD PATIENTS (2017) (0)
Neurohumoral response to volume depletion and central hypovolemia in dialysis patients. (1996) (0)
Radiation risk of cancer from medical imaging in end stage kidney disease patients: Italian nationwide survey (2016) (0)
Contents Vol. 32, 2010 (2010) (0)
FO032THE PHYSICAL ACTIVITY COMPONENT OF THE SF36 IS THE QoL DOMAIN HOLDING THE HIGHEST PREDICTIVE POWER FOR SURVIVAL IN THE DIALYSIS POPULATION (2015) (0)
FP284DOWNREGULATION OF INTACT FIBROBLAST GROWTH FACTOR 23 (IFGF23) AND ASYMMETRIC DIMETHYL ARGININE (ADMA) AND αKLOTHO UPREGULATION DURING ACUTE INFLAMMATION/SEPSIS IN STAGE 2-5 CKD PATIENTS (2015) (0)
PowerPoint Slides for: Arterial Stiffness as a Cardiovascular Risk Factor in Stage 5D Chronic Kidney Disease Patients: An Age Affair (2016) (0)
Under embargo until June 2 , 2014 , 09 : 30 local time ! LATE BREAKING CLINICAL TRIALS Hyperparathyroidism : Medical or Surgical Treatment ? (2014) (0)
The Gore-Tex biomaterial mesh as temporary divisor in two times surgery for spinal and pelvic tumors (2010) (0)
Megaprosthesis for Metastasis of the Lower Limb (2018) (0)
Faculty Opinions recommendation of Blood pressure in early autosomal dominant polycystic kidney disease. (2014) (0)
SP724SLEEP DISORDERED BREATHING (SDB) REEMERGENCE AND SYSTEMIC HYPERTENSION IN RENAL TRANSPLANT PATIENTS: A LONGITUDINAL STUDY (2019) (0)
[Long-term treatment with propranolol of hypertension resistant to dialysis]. (1975) (0)
[Initiating dialysis early or late? New questions and new proposals]. (2010) (0)
MO109CHARACTERIZATION OF RESISTANT HYPERTENSION IN CKD PATIENTS (2021) (0)
[Update of the Italian Society of Nephrology Project No. 1 of the 2004-2006 SIN programme]. (2006) (0)
Clinical hypertension in nephrology : international meeting, Lido degli Aranci, Calabria, September 20-23, 1995 (1996) (0)
Faculty Opinions recommendation of Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. (2014) (0)
P1.21 Microrna Profiling as a Potential Predictive Tool of Giant Cell Tumor Evolving in High Grade Osteosarcoma: A Case Report (2012) (0)
Polymorphisms in the genes of the renin system and progression of renal disease: a critical review. (2001) (0)
Kidney Disease and Population Health (2009) (0)
Contents Vol. 116, 2010 (2010) (0)
Letter by Kielstein et al regarding article, "Renal function as a predictor of outcome in a broad spectrum of patients with heart failure". (2006) (0)
In Reply to 'Lung Ultrasound in Hemodialysis Patients: Is it Practical to Scan 28 Zones?' (2020) (0)
PP.03.29: VISIT TO VISIT BLOOD PRESSURE (BP) VARIABILITY AND CAROTID ATHEROSCLEROSIS IN RENAL TRANSPLANT PATIENTS (2015) (0)
Is oxidative stress implicated in high bone turnover in end-stage renal disease (ESRD)? (2006) (0)
FP771A LONGITUDINAL, LONG TERM, ANALYSIS OF SLEEP DISORDERED BREATHING IN RENAL TRANSPLANT PATIENTS (2019) (0)
A Rare Case of First Metatarsal Extrusion: Results of Treatment After 12 Months. (2019) (0)
Faculty of 1000 evaluation for Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. (2018) (0)
Annual Congress of the Blood Purification Management Branch of Chinese Hospital Society, August 11-14, 2016, Nanjing, China: Selected Abstracts (2017) (0)
Fibrous dysplasia: an unusual case of a very aggressive form with costo-vertebral joint destruction and invasion of the contralateral D7 vertebral body (2018) (0)
Original Investigation A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study (2014) (0)
Should we consider altering our patterns of care for elderly sarcoma patients? (2018) (0)
Faculty Opinions recommendation of Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy. (2019) (0)
SaO002ASYMMETRIC (ADMA) AND SYMMETRIC (SDMA) DIMETHYLARGININE AND SYMPATHETIC NERVE TRAFFIC AFTER RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION: A LONGITUDINAL STUDY (2015) (0)
FO041THE EFFECT OF DRY-WEIGHT REDUCTION GUIDED BY LUNG ULTRASOUND ON AMBULATORY BLOOD PRESSURE IN HEMODIALYSIS PATIENTS: A LUST SUB-STUDY (2019) (0)
J13: Hypertension and nocturnal hypoxemia in chronic renal failure (1997) (0)
FP376THE BURDEN OF CKD IN HIGH RISK CONDITIONS IN THE AFRICAN CONTINENT: A SYSTEMATIC REVIEW (2015) (0)
HETEROGENEITY OF BLOOD PRESSURE RESPONSE TO VOLUME EXPANSION AND DEPLETION MANOEUVRE DURING THE GRIM TEST OF SALT-SENSITIVITY: P1.72 (2000) (0)
Faculty of 1000 evaluation for The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus. (2011) (0)
SP383THE CKD EPIDEMIC IN THE AFRICAN CONTINENT: A SYSTEMATIC REVIEW (2015) (0)
FP340EPIDEMIOLOGY OF HYPERKALIEMIA IN CKD: A LONGITUDINAL STUDY (2018) (0)
SP358PULMONARY HYPERTENSION PREDICTS ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-ADVANCED CKD (2015) (0)
Faculty Opinions recommendation of Disruption of methylarginine metabolism impairs vascular homeostasis. (2008) (0)
Faculty Opinions recommendation of Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study. (2017) (0)
Heart Biomarkers of Left Atrial Volume A Longitudinal Study in Patients With End Stage Renal Disease (2009) (0)
Opponent's comments. (2015) (0)
[Hyperchloremia and metabolic acidosis in chronic kidney failure]. (1984) (0)
Tales of two study designs in patients with chronic kidney failure: The case of the protein–energy wasting – inflammation syndromic complex (2021) (0)
[Cardiac output and pulmonary blood volume in arterial hypertension of chronic uremia]. (1980) (0)
SYMPATHETIC ACTIVATION IN CONGESTIVE HEART FAILURE AND ITS CORRELATES (2019) (0)
MP717CORRECTION OF FLUID OVERLOAD SUSTANTIALLY REDUCES MORTALITY IN STABLE VOLUME-EXPANDED HEMODIALYSIS PATIENTS (2017) (0)
Dyslipidemia in Chronic Renal Disease (2011) (0)
SP291HIGH SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) AND THE RISK OF DEATH AND CARDIOVASCULAR (CV) EVENTS IN STAGE 2-5 CKD PATIENTS (2016) (0)
Genetic diseases and molecular genetics (2013) (0)
Faculty Opinions recommendation of Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). (2008) (0)
Exit site infection in peritoneal dialysis patients : Prevalence in a single center and evaluation of a nursing chart (1997) (0)
Faculty Opinions recommendation of Intensive Supportive Care plus Immunosuppression in IgA Nephropathy. (2016) (0)
ASYMMETRIC DIMETHYLARGININE (ADMA) IS RELATED TO THE SEVERITY OF ATHEROSCLEROSIS AND PREDICTS MORTALITY IN END STAGE RENAL DISEASE (ESRD): P1.68 (2000) (0)
[Clinical trials (Part II)]. (2010) (0)
[Linear regression analysis in clinical research]. (2011) (0)
News & Views (2017) (0)
Asymmetric dimethylarginine is a strong predictor of death in a population based cohort study in the elderly (2011) (0)
FP324CHRONIC KIDNEY DISEASE PREVALENCE: VARIATION ACROSS THIRTEEN EUROPEAN COUNTRIES (2015) (0)
Cardiomyopathy in Chronic Kidney Disease and in End-stage Renal Disease (2010) (0)
[Obesity and chronic kidney disease]. (2010) (0)
ADPKD - CLINICALOUTCOME STUDIES (2014) (0)
Assessment of left ventricular function by 2D-speckle tracking echocardiography imaging in renal transplanted patients (2015) (0)
SP339A GENETIC MARKER OF HYPERURICEMIA PREDICTS CARDIOVASCULAR EVENTS IN A META-ANALYSIS OF THREE COHORT STUDIES IN HIGH RISK PATIENTS (2015) (0)
Faculty Opinions recommendation of Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. (2009) (0)
Faculty Opinions recommendation of Red meat intake and risk of ESRD. (2017) (0)
SP296THYROID FUNCTIONAL DISORDERS ASSOCIATED WITH MORTALITY IN CHRONIC KIDNEY DISEASE: ASYSTEMATIC REVIEW AND META-ANALYSIS (2016) (0)
FP760COMPARATIVE EFFECTIVENESS OF DIFFERENT ANTIHYPERTENSIVE AGENTS IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS (2019) (0)
SuO006TWO MAJOR INSULIN RESISTANCE GENES (SIRT1 AND SIRT6) ARE ASSOCIATED WITH CONCENTRIC LEFT VENTRICULAR HYPERTROPHY IN END STAGE KIDNEY DISEASE (2015) (0)
Erratum. (2020) (0)
POOR ADHERENCE TO BLOOD PRESSURE MEASUREMENT RECOMMENDATIONS IN EUROPEAN DIALYSIS CENTERS (2018) (0)
P0831HIGH SERUM ALKALINE PHOSPHATASE PREDICTS THE RISK OF CKD PROGRESSION: EFFECT NODIFICATION BY THE GFR (2020) (0)
[Guidelines: general principles and clinical application in nephrology]. (2014) (0)
Neuropeptide Y receptor Y2 gene and LVH in dialysis patients (2015) (0)
Tumor response assessment in locally unresectable or metastatic soft tissue sarcoma (aSTS) patients (pts): A three-year Regina Elena Cancer Institute (IRE) experience with trabectedin therapy. (2013) (0)
Inflammation biomarkers and inflammatory genes expression in metabolically healthy obese patients. (2022) (0)
[The chronic renal failure epidemic: an underestimated public health problem]. (2007) (0)
Faculty Opinions recommendation of Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. (2008) (0)
Propensity to calcification as a pathway to renal hypoxia in chronic kidney disease and in hypertension. (2017) (0)
[SIN-SIBIOC and SIMEL recommendations for glomerular filtrate assessment on plasma creatinine concentration estimates]. (2009) (0)
Faculty Opinions recommendation of Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2. (2007) (0)
SP543AMBULATORY ARTERIAL STIFNESS PARAMETERS PREDICT CARDIOVASCULAR AND ALL-CAUSE MORTALITY BETTER THAN OFFICE AND AMBULATORY BLOOD PRESSURE IN HEMODIALYSIS PATIENTS (2017) (0)
Faculty Opinions recommendation of Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension. (2019) (0)
[Decrease of hospital admissions in nephrology through the use of outpatient clinics]. (1979) (0)
Faculty Opinions recommendation of Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials. (2018) (0)
[OP.2B.05] LONG TERM, BUT NOT SHORT TERM, BLOOD PRESSURE VARIABILITY PREDICTS CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS (2016) (0)
Dialysis Transplantation Evidence-based medicine : the clinician ’ s perspective (1999) (0)
SO045A NATIONWIDE SURVEY ON RADIATION RISK OF CANCER FROM MEDICAL IMAGING IN END STAGE KIDNEY DISEASE AND IN TRANSPLANT PATIENTS (2016) (0)
SALT-SENSITIVITY DOES NOT IMPLICATE NOCTURNAL HYPERTENSION: P1.69 (2000) (0)
Risk, Predictors, and Outcomes of Acute Kidney Injury in Patients Admitted to Intensive Care Units in Egypt (2017) (0)
Faculty Opinions recommendation of Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. (2019) (0)
SP329THE POTENTIAL OF URINARY BIOMARKERS TO IMPROVE RISK STRATIFICATION FOR CKD PROGRESSION: A PILOT STUDY (2017) (0)
Contents, Vol. 44, 1986 (1986) (0)
SP621PROGNOSTIC VALUE OF LEFT ATRIAL VOLUME IN ESKF PATIENTS (2017) (0)
About the manuscript of nishitani Y et al. Authors' reply (2006) (0)
Evidence-based medicine. A critical view from the clinician. (2001) (0)
Salt intake and hyperfiltration. (1996) (0)
Faculty Opinions recommendation of A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus. (2018) (0)
Subject Index, Vol. 56, 1990 (1990) (0)
Genetic studies in renal diseases (2012) (0)
Seven essential tools of a cardiologist's survival kit. (2015) (0)
Humoral and hemodynamic correlates of hepatocyte growth factor in end stage renal disease (1999) (0)
Erratum: The quality of reporting in clinical research: The CONSORT and STROBE initiatives (Aging - Clinical and Experimental Research DOI: 10.1007/s40520-013-0007-z)) (2013) (0)
1689PHMGA1 is a new biomarker of liposarcoma progression (2017) (0)
About the manuscript of Nishitani Y et al. (Kidney Int 2005; 68: 1078-1085). (2006) (0)
MP315GENETIC VARIABILITY IN THE ALKALINE PHOSPHATASE GENE (ALPL) PREDICTS DEATH AND LEFT VENTRICULAR REMODELLING IN END STAGE KIDNEY DISEASE (ESKD): AN EXPLORATORY, MENDIALIAN RANDOMIZATION STUDY (2016) (0)
A overv r iew of standard stat a istical methods fo f r assessing exposure-outcome link i ns urv r iv (2012) (0)
SaO048THE EFFECT OF DRY-WEIGHT REDUCTION GUIDED BY LUNG ULTRASOUND ON AMBULATORY AORTIC BLOOD PRESSURE AND ARTERIAL STIFFNESS PARAMETERS IN HEMODIALYSIS PATIENTS: A LUST SUB-STUDY (2019) (0)
Subject Index, Vol. 44, 1986 (1986) (0)
FP763OXIDATIVE STRESS AMPLIFIES THE ALKALINE PHOSPHATASE - DEPENDENT RISK FOR MORTALITY IN ESKD PATIENTS ON DIALYSIS (2015) (0)
Lab methods, progression & risk factors for CKD - 1 (2009) (0)
Faculty of 1000 evaluation for Angiotensin Blockade in Late Autosomal Dominant Polycystic Kidney Disease. (2015) (0)
Letter to the editor about the reviewer comment to our article entitled 'Procalcitonin and the inflammatory response to salt in essential hypertension: a randomized cross-over clinical trial'. (2013) (0)
Subject Index Vol. 113, 2009 (2009) (0)
Cutaneous cyanoacrylate glue and silastic patch to reduce the risk of tumor wide spreading after incisional biopsy. (2014) (0)
[Quality certification project for chronic renal failure management]. (2008) (0)
[How to measure effects in clinical research (corrected)]. (2010) (0)
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage]. (2022) (0)
Periosteal Aneurysmatic Bone Cyst: A Rare Case Treated by Pre-Surgery Endovascular Embolization (2021) (0)
[Interaction analysis in epidemiological research]. (2011) (0)
SP256CHEST ULTRASOUND (US)AND CLINICAL CRITERIA TO DETECT AND MONITOR CARDIOPULMONARY COMPLICATIONS IN PATIENTS WITH ACUTE KIDNEY INJURY: A PILOT STUDY (2015) (0)
SP608LEFT VENTRICULAR MASS IS A POWERFUL PROGNOSTIC FACTORFOR ALL-CAUSE MORTALITY IN END STAGE KIDNEY DISEASE PATIENTS: A COMBINED ANALYSIS OF TWO EUROPEAN COHORTS (2016) (0)
Parasympathetic neuropathy and LVH. (2005) (0)
The C1839t Polymorphism in the E-Selectin Gene is Associated with Intimal Thickening, Arterial Remodelling and Stenosis in ESRD Patients: 3.9 (2005) (0)
[OP.4D.08] DISORDERED SLEEP BREATHING (SDB) IS THE MAJOR DETERMINANT OF NON-DIPPING AND NOCTURNAL HYPERTENSION IN KIDNEY TRANSPLANT PATIENTS (2016) (0)
MAJOR ADIPOSE TISSUE CYTOKINES LEPTIN AND ADIPONECTIN INTERACT WITH CENTRAL OBESITY IN EXPLAINING THE VARIABILITY IN ALL-CAUSE AND CARDIOVASCULAR DEATH IN A HIGH RISK POPULATION: PP.9.345 (2010) (0)
The valuable contribution of observational studies to (2007) (0)
P0597TRAINING IS NOT ENOUGH: RESISTANCE TO THE APPLICATION OF THE AGREED CRITERIA (KDIGO) FOR THE DIAGNOSIS OF ACUTE KIDNEY INJURY IN INTENSIVE CARE UNITS IN EGYPT (2020) (0)
Progression and mortality in patients with CKD attending outpatient nephrology clinics across Europe: A novel analytic approach (2018) (0)
A New Treatment for Calciphylaxis in Hemodialysis Patients? (2018) (0)
Full Review Non-proteinuric rather than proteinuric renal diseases are the leading cause of end-stage kidney disease (2017) (0)
Interarm systolic blood pressure as a predictor of cardiovascular events in patients with chronic kidney disease (2015) (0)
SP462TIME-INTEGRATED EXPOSURE TO FLUID OVERLOAD AND BLOOD PRESSURE PREDICTS MORTALITY IN HEMODIALYSIS PATIENTS (2016) (0)
Faculty Opinions recommendation of Serum calcification propensity predicts all-cause mortality in predialysis CKD. (2014) (0)
Faculty Opinions recommendation of Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. (2014) (0)
B023: Analysis of blood pressure response to volume expansion and depletion manoeuvre during the grim test of salt-sensitivity (2000) (0)
[Salt and hypertension in the 90's: a settled controversy?]. (1992) (0)
Faculty Opinions recommendation of A randomized trial of strategies using darbepoetin alfa to avoid transfusions in CKD. (2021) (0)
Correction: Estimated Glomerular Filtration Rate, All-Cause Mortality and Cardiovascular Diseases Incidence in a Low Risk Population: The MATISS Study (2014) (0)
Dysuria as presenting symptom of necrotizing glomerulonephritis. (1993) (0)
MP350VITAMIN D RECEPTOR ACTIVATION INCREASES SERUM SCLEROSTIN IN CKD PATIENTS: A RANDOMIZED CLINICAL TRIAL (2016) (0)
Efficacy and safety of antidepressants for depression in stage 3 to 5 chronic kidney disease: A systematic review by European renal best practice (2011) (0)
MP344THE INTERDIALYTIC PERIOD FOR BLOOD COLLECTION INFLUENCES SERUM PHOSPHORUS AND THE RISK OF MORTALITY IN THE COSMOS STUDY (2016) (0)
Genetics and Pharmacogenomics (2008) (0)
Diabetic nephropathy in normotensive patients. Discussion (1990) (0)
4.1 The B Allele of the BsmI Vitamin D Receptor (VDR) Gene Polymorphism is Independently Associated to LVH and to Higher Progression Rate of LVH in End-Stage Renal Disease (ESRD) Patients (2008) (0)
Faculty of 1000 evaluation for Blood pressure in early autosomal dominant polycystic kidney disease. (2015) (0)
SO022VITAMIN D RECEPTOR ACTIVATION DOES NOT IMPROVE INSULIN SENSITIVITY IN PATIENTS WITH STAGE 3 TO 4 CHRONIC KIDNEY DISEASE (2017) (0)
Renal transplantation - clinical studies - 2 (2009) (0)
M014: Pulse pressure and malnutrition are the main determinants of vascular damage in dialysis patients (1998) (0)
Faculty Opinions recommendation of Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. (2020) (0)
NDT Perspectives Risk prediction models (2013) (0)
MO029LONG TERM, BUT NOT SHORT TERM, BLOOD PRESSURE VARIABILITY PREDICTS CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEYDISEASE PATIENTS (2016) (0)
Role of Obesity and Metabolic Alterations in Hypertensive Renal Disease and in Chronic Kidney Disease (2011) (0)
The Expanding Uraemic Population (1994) (0)
FP743A PARADIGM SHIFT IN NUTRITIONAL DISORDERS AS CLASSIFIED BY THE BMI IN THE DIALYSIS POPULATION IN TWO SOUTHERN EUROPEAN RENAL REGISTRIES: ASCEDANCY OF OVERWEIGHT AND OBESITY AND DECLINE OF UNDERWEIGHT CATEGORIES (2015) (0)

This paper list is powered by the following services:

Other Resources About Carmine Zoccali

en.wikipedia.org

What Schools Are Affiliated With Carmine Zoccali?

Carmine Zoccali is affiliated with the following schools:

Carmine Zoccali's Academic­Influence.com Rankings